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ABSTRACT 
 
Background 
Plasmodium falciparum malaria during pregnancy poses a substantial risk to mother 
and foetus. In recent years, convincing evidence has shown that preventive methods 
such as the use of insecticide treated bed nets (ITNs) and intermittent preventive 
treatment (IPT) in pregnancy with sulphadoxine-pyrimethamine (IPTp-sp) can greatly 
reduce the adverse effects of malaria during pregnancy. 
 
Purpose  
The main purpose of the study was to assess the knowledge and use of Intermittent 
Preventive Treatment of Malaria among pregnant women receiving Antenatal Care at 
the primary health centers of the Federal Capital Territory, Abuja Nigeria. 
 
Methods  
A quantitative, descriptive, cross-sectional study was conducted Structured 
questionnaires were administered to 300 pregnant women aged between 18 and 49 
years. Data was analysed using Statistical Package for Social Sciences (SPSS) 22.  
 
Results 
The results revealed that most of the respondents had knowledge about IPT, majority of 
the respondents had received IPT drugs, in the clinic, but unfortunately none of them 
were supervised by a health worker during taking of the drug. Few of the respondents 
did not take the drugs at all for fear of complication, some of them did not know exactly 
how many tablets were given to them and there was poor adherence to the Directly 
Observed Therapy (DOT) scheme. 
 
Conclusion 
Knowledge of malaria and IPT was good and many pregnant women received the drugs 
and used it, but some of them had challenges and did not use the drugs.  
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pregnant women; antenatal clinic. 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
Malaria is a parasitic disease of humans especially in the sub-Saharan Africa, where 
about 90% of death occurred due to malaria. The burden of the disease is enormous in 
malaria endemic countries like ours. Approximately 50 million women living in malaria 
endemic countries throughout the world become pregnant each year. An estimated 
10,000 of these women and 200,000 of their infants die as a result of malaria infection 
(Nwali, Ejikeme, Agboeze, Onyebuchi & Anozie 2015:2). 
 
Pregnant women are particularly vulnerable to malaria as pregnancy reduces a 
woman’s immunity, making them more susceptible to infection and increasing the risk of 
illness, and causing severe anaemia and death. For the foetus, maternal malaria 
increases the risk of spontaneous abortion, still birth, premature delivery and low birth 
weight (Purohit & Mahapatra 2009:34). 
 
In areas with moderate-to-high transmission of malaria, primigravidae are at highest risk 
of malaria infection followed by secundi-gravidae, the risk diminishing with each 
consecutive pregnancy. Malaria infection is more frequent and severe in primigravidae 
both during, pregnancy and at the time of delivery. Adolescence is an independent risk 
factor for malaria in pregnancy, with much higher prevalence of malaria in women aged 
15-19 years, and younger adolescents might be at a higher risk than older adolescents 
due to immunological and hormonal factors (Hill 2014:3). 
 
Malaria is caused primarily by plasmodia of various types – Plasmodium ovale, 
Plasmodium malaria, Plasmodium vivax and Plasmodium falciparum. Of these four 
species of plasmodia, Plasmodium falciparum causes the most severe malaria illness 
and death throughout the world. As of 2006 it accounted for 91% of all the 247 million 
human malarial infections (98% in Africa). Plasmodium falciparum is known to be the 
most devastating in Nigeria. The transmission of the parasite is facilitated through the 
bite of the female anopheles mosquito (FMOH 2010:1). 
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Plasmodium falciparum malaria during pregnancy poses a substantial risk to mother 
and foetus. In recent years, convincing evidence has shown that preventive methods 
such as the use of insecticide treated bed nets (ITNs) and intermittent preventive 
treatment (IPT) in pregnancy with sulphadoxine-pyrimethamine (IPTp-sp) can greatly 
reduce the adverse effects of malaria during pregnancy and since 1998 this measures 
has been recommended by the World Health Organization (WHO) (Mens, Scheelbeek, 
Atabbi & Enato 2011:1). 
 
The knowledge of antenatal women will determine whether they will use IPT during 
pregnancy or not hence the study is very crucial. 
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM  
 
1.2.1 The source of the research problem 
 
Global issues 
 
Malaria is one of the world’s most common and serious tropical diseases, with half the 
world’s population at risk of being infected with malaria.  
 
More than three billion people in nearly 100 countries are at risk from malaria. Sub-
Saharan Africa is the hardest hit region in the world, and parts of Asia and Latin 
America also face significant malaria epidemics. Many challenges continue to 
complicate malaria control efforts in countries with ongoing malaria transmission, 
including poverty, poor sanitation, weak health systems, limited disease surveillance 
capabilities, natural disasters, armed conflict, migration, climate change, and the 
presence of counterfeit and/or sub-standard antimalarial drugs (Global Health Policy 
2015). 
 
Sabin, Rizal, Brooks, Singh, Tuchman, Wylie, Joyce, Yeboa-Antwi, Singh and Hammer 
(2010:1010) in their study, reported that malaria is endemic in India and constitutes a 
major public health challenge and an estimated 2–3 million malaria cases resulting in 
500–800 deaths are reported annually nationwide, with 95% of India's population at risk 
of infection. 
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Sub-Saharan Africa 
 
More than half of the world's population is at risk of malaria and the vast majority of 
cases are from sub-Saharan Africa, where about 30 million pregnant women are highly 
exposed to the disease each year, pregnancy associated malaria results in severe 
consequences such as parasite sequestration in the placental vascular space. This 
could lead to morbidity and mortality, abortion, stillbirth, low birth weight (due to intra-
uterine growth retardation and prematurity), and transplacental transmission of the 
malaria parasite (Tonga, Kimbi, Achang-Kimbi, Nyabeyeu, Bissemou & Leman 2013:1). 
 
In many African countries, malaria is holo-endemic and non-pregnant female adults 
have a significant level of immunity against malaria. However, during pregnancy, these 
women experience a considerable decrease in their levels of immunity to malaria and 
several studies have reported that 1st and 2nd pregnancies are associated with a higher 
prevalence of malaria in the first half of pregnancy in women living in endemic malarious 
areas (Nwonwu, Ibekwe, Ugwu, Obarezi & Nwagbara 2009:182). 
 
Nigeria 
 
Situated between 4° and 13° Northern Latitude, Nigeria has a suitable climate for 
malaria transmission throughout the country. The only exception is the area South of 
Jos in Plateau State where some mountain peaks reach 1600 meters and the altitude of 
settlements lies between 1200 and 1400 meters. This area can be considered of low or 
very low malaria risk (FMOH 2008:12). 
 
Bassey, Asor and Useh (2007:2) stated that malaria transmission is increasing in 
Nigeria due to deforestation, cultivation of wetlands, poor environmental sanitation, 
other man made breeding sites such as construction works, brick pits or fish ponds, 
among others, all of which create breeding sites for Anopheles mosquito. 
 
In Nigeria, malaria accounts for 60% of outpatients consultations and 11% of maternal 
mortality is due to malaria in pregnancy. 70% of pregnant women in Nigeria suffer 
malaria with maternal and fetal complications (Nwali et al 2015:2). 
  
4 
FMOH (2010:1,2) mentioned that malaria is a major public health problem in Nigeria 
and that it accounts for 25% of under-5 mortality, 30% of childhood mortality and 11% of 
maternal mortality. 
 
An estimated 500,000 women die each year throughout the world from complications of 
pregnancy and childbirth. About 55,000 of these deaths occur in Nigeria. Nigeria, with 
only 2.0% of the world’s population therefore accounts for over 10.0% of the world’s 
maternal deaths (Nwosu, Odubanjo & Osinusi 2009:14). 
 
Maternal mortality in Nigeria is not uniform across the country but varies markedly 
across geographical zones. This has been attributed to differences in a range of factors 
such as wealth indices, educational level, cultural practices, and healthcare coverage 
and utilisation (Nwosu et al 2009:15). 
 
Some of the problems affecting prevention of malaria in pregnancy include low level of 
education leading to poor compliance to medication, poor antenatal care attendance 
and non-appreciation of the need to take drugs while they are physically fit (FMOH 
2010:20).  
 
Several studies have suggested that both adherence to malaria treatment and uptake of 
malaria prevention activities are linearly associated with knowledge of the adverse 
health effects of malaria (Mens et al 2011:2). 
 
In a study conducted by Akinleye, Falade and Ajayi (2009:1) on the knowledge and 
utilisation of IPT for malaria among pregnant women receiving antenatal care in primary 
health centers in rural southwest, Nigeria, out of the 209 subjects, One hundred and 
nine of the 209 (52.2%) respondents have heard about IPT but only 26 (23.9%) were 
able to define it. Fifty-seven (27.3%) reported to have received at least one dose of IPT 
during the index pregnancy and all were among those who have heard of IPT (52.3%). 
Twenty one of the 57 (36.8%) took the SP in the clinic. Only three of the twenty-one 
(14.3%) were supervised by a health worker. Twenty two of the 36 women (61.1%) who 
did not take their drugs in the clinic would have liked to do so if allowed to bring their 
own drinking cups. Almost half (43.9%) of those who had used IPT during the index 
pregnancy expressed concern about possible adverse effect of SP on their 
pregnancies. Periodic shortages of SP in the clinics were also reported. In their study, 
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IPT use among pregnant women was very low and there was poor adherence to the 
Directly Observed Therapy (DOT) scheme. 
 
Akinleye et al (2009:5) attributed the reason for the low uptake to the low level of 
awareness and poor knowledge of the use of IPT by the pregnant women. They 
assumed that the low use of IPT and poor adherence may not be peculiar to southwest 
Nigeria alone and the findings in their study may be a proxy to the practice of IPT in 
primary health care (PHC) centres in other parts of the country.   
 
In a study on the awareness and practice of malaria prevention strategies among 
pregnant women in Uyo, south-south Nigeria, only 40.8% of the patients had heard of 
IPT, while 12.0% received drugs under IPT (Abasiattai, Etukumana & Umoiyoho 
2009:1). The level of utilisation of ITNs and IPT in their study was low. 
 
In two cross-sectional studies conducted in Muhezaand Mpwapwa districts in Central 
Tanzania, low compliance with the use of SP was partly attributed to shortage of 
antenatal care (ANC) personnel and users' fear of side effects of SP and their 
inadequate knowledge of the correct dose (Mubyazi, Bloch, Kamugisha, Kitua & Ijumba 
2005:4, 5).  
 
1.2.2 Background of the research problem 
 
Nigeria is the most populous country in Africa with an annual growth rate of about 3.2% 
and a total population of approximately 150 million. It is made up of 36 states (plus the 
Federal Capital Territory of Abuja), and 774 Local Government Authorities (LGAs), each 
with a population of about 100,000 to 200,000 residents (President’s Malaria Initiative 
2010:9). 
 
Abuja, the Federal Capital Territory (FCT) is a "planned" city, as it was mainly built in 
the 1980s and officially became Nigeria's capital on 12 December 1991, replacing the 
role of the previous capital Lagos. As of the 2006 census, the FCT has a population of 
778,567 (UNFPA 2010:7). 
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According to the FCT millennium development goals, the FCT covers a total land area 
of approximately 8,000 square kilometers and it is presently made up of 6 Area Councils 
– Municipal Abaji, Bwari, Gwagwalada, Kuje and Kwali (FCT 2009). 
 
Malaria is a major public health problem in Nigeria, accounting for about 60% of all 
outpatient attendances and 30% of all hospital admissions. Malaria’s economic impact 
is enormous with about N132 billion ($825 million) lost to Malaria annually in form of 
treatment costs, prevention, loss of man hours, etc (FMOH 2010:5). 
 
According to the Nigeria Malaria fact sheet (United States Embassy in Nigeria 2011). 
Malaria is a major public health problem in Nigeria where it accounts for more cases 
and deaths than any other country in the world. Malaria is a risk for 97% of Nigeria’s 
population. The remaining 3% of the population live in the malaria free highlands.  
 
Malaria is endemic throughout Nigeria with seasonal variation in different geographic 
zones of the country (Abdullahi, Abubakar, Adamu, Daneji, Aliyu, Jiya, Ibraheem & 
Nata’ala 2009:7102). 
 
Ninety five percent of malaria infections in Nigeria are caused by Plasmodium 
falciparum and five percent by Plasmodium malariae (Okwa, Akinmolayan, Carter & 
Hurd 2009:2). 
 
Malaria is transmitted by the infectious bites of female anopheles mosquitoes. These 
mosquitoes carry infective sporozoites in their salivary gland, which they transfer to the 
blood stream of man during a blood meal (Okwa & Ibidapo 2010:213). 
 
Transmission is most intense in the wet season as compared to the dry season. This 
seasonal difference is more striking in the northern part of the country (FMOH 2011:10). 
 
Malaria is particularly virulent in pregnant women and children because of their low 
levels of immunity (Uzochukwu, Ezeoke, Ukaegbu, Onwujekwe & Sibeudu 2010:114). 
Concerns over the burden of malaria led to the development of several global control 
strategies and targets such as those under the millennium development goals (MDG) 
and roll back malaria (RBM) which were set in order to encourage malaria endemic 
countries to control the disease. Intermittent preventive treatment (IPT) for prevention of 
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malaria in pregnancy is a key component of malaria control strategy in Nigeria and 
sulphadoxine pyrimethamine (SP) is a drug of choice. Despite the evidence of the 
effectiveness of IPT strategy using SP in reducing the adverse effects of malaria during 
pregnancy, the uptake and coverage in Nigeria is low (Uzochukwu et al 2010:116; Mens 
et al 2011:1). 
 
In 2001, Nigeria instituted IPT using SP for pregnant women in the second and third 
trimesters of pregnancy.  
 
IPT involves the administration of therapeutic doses of an antimalarial drug to a 
population at risk whether or not they are known to be infected, at specific point 
intervals usually with the aim of reducing morbidity and mortality. In 2002, the World 
Health Organization (WHO) developed a strategic framework for the control of malaria 
during pregnancy in Africa. The document recommends that pregnant women receive at 
least two doses of SP as IPT during the second and third trimesters during the routine 
antenatal visit (Aduloju, Ade-ojo, Olaogun, Olofinbiyi & Akintayo 2013:8-9). 
 
Successful deployment of IPT is dependent on the utilisation rates of ANC services 
amongst pregnant women (Onoka, Hanson & Onwujekwe 2012:2). 
 
According to the 2008 Demographic and Health Survey (DHS), more than 55% of 
pregnant women attended an antenatal clinic (ANC) at least once during their 
pregnancy. In the 2008 DHS, only 8% of pregnant women had received one or more 
doses of SP and 5% received the recommended two doses for IPTp (President’s 
Malaria Initiative 2010:46). 
 
With this background, some of the research questions that will be addressed in this 
study include: 
 
(i) What is the level of knowledge about malaria and its consequences among 
pregnant women? Do they know it can be prevented? 
(ii) What are the factors (socio-economic and cultural) that may influence IPT uptake 
among the pregnant women attending ANC in health centers, in Abuja Nigeria? 
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To date, there are few studies that assessed the knowledge of malaria and IPT use 
among pregnant women in Abuja, Nigeria, hence the reason for this study. 
 
1.3 RESEARCH PROBLEM 
 
In Nigeria, malaria accounts for 11.0% maternal deaths (Aduloju et al 2013:8). Parasite 
prevalence in pregnant women in Nigeria could be as high as 60-70%. These women 
are infected with Plasmodium falciparum, the most virulent Plasmodium with serious 
health consequences including anaemia, impaired foetal growth, still birth, and 
premature delivery (Onoka et al 2012:1). 
 
Malaria is the third leading cause of death for children under five years worldwide, after 
pneumonia and diarrheal disease. Malaria is a major public health problem in Nigeria 
where it accounts for more cases and deaths than any other country in the world. 
Malaria is a risk for 97% of Nigeria’s population. The remaining 3% of the population live 
in the malaria free highlands. There are an estimated 100 million malaria cases with 
over 300,000 deaths per year in Nigeria (Onwumele 2014:80).  
 
Up to 20% of pregnant women in endemic areas have asymptomatic parasitemia and a 
recent study showed that about 40% of these will present with clinical malaria within a 
four week period. Women with pre-eclampsia have also been shown to have a three-
fold increased risk of malaria parasitemia (Okpere, Enabudoso & Osemwenka 2010). 
 
According to the National Bureau of Statistics Nigeria (2012:23, 25) the total number of 
pregnant women who had malaria in the years 2007-2011 were as follows:  
 
2007:  352,942 
2008:  347,996 
2009:  475,414 
2010:  330,249 
2011:  359,612 
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While the reported deaths were as follows: 
 
2007:  1,642 
2008:  477 
2009:  387 
2010:  193 
2011:  257 
 
Malaria is associated with 11.0% of all maternal deaths and 70.5% of morbidity in 
pregnancy. It accounts for up to 15% of maternal anaemia, 5%-14% of low birth weight 
(LBW).  
 
It is reported that one person in Africa dies of malaria every 10 seconds and pregnant 
women and children under five are most at risk. It is equally indicated that other burden 
associated with malaria in pregnancy include but not restricted to spontaneous abortion 
and miscarriage, still-birth, socio-economic status of the family is affected in terms of 
using scarce resources on preventable condition (Chukwuocha, Dozie, Chukwuocha 
2012:147).  
 
To tackle this enormous burden, lPTp SP or also referred to as Fansidar is given to 
pregnant women during ANC. WHO recommends that SP should be given at each 
scheduled ANC visit except during the first trimester. The first dose of three tablets IPTp 
can be administered within the 16th week of gestation, and dosage can be repeated 
every month at least one month apart — i.e. the second dose IPTp given within the 20th 
week of pregnancy — until the time of delivery (Chikwasha, Phiri, Chimberengwa, 
Bangure & Rusakaniko 2014:1). 
 
Intermittent preventive treatment in pregnancy (IPTp) involves the administration of 
therapeutic doses of an antimalarial drug to a population at risk whether or not they are 
known to be infected, at specific point intervals usually with the aim of reducing 
morbidity and mortality (Aduloju et al 2013:8-9). 
 
A number of studies have found the quality of ANC services in Nigeria to be 
characterised by low coverage, inadequate content, inadequate personnel, poor 
technical skills among personnel and low utilisation of effective interventions. Mothers at 
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highest risks of adverse pregnancy outcomes lack access to effective and quality ANC 
(The Nigerian Academy of Science 2009:32). 
 
Successful deployment of IPTp is dependent on the utilisation rates of ANC services 
amongst pregnant women. Attendance at ANC is high in most sub-Saharan African 
countries, but up to 25% of pregnant women pay the first visit in the 3rd trimester. This 
may affect the impact of ANC and IPTp related services as delivery of the second dose 
of SP is substantially reduced and envisaged protection for mother and foetus is lost 
(Onoka et al 2012:2). 
 
IPTp with SP has proven efficacious in reducing the incidence of pregnancy-associated 
malaria and is currently part of the national malaria prevention programme in most 
countries in Africa (Deloron, Bertin, Briand, Massougbodji & Cot 2010:1667). 
 
Mens et al (2011:2) state that success rates of any treatment or prevention focused 
intervention is, thus, likely to be determined by the level of awareness of the risks of 
malaria and the level of knowledge on available strategies to prevent it. Several studies 
have suggested that both adherence to malaria treatment and uptake of malaria 
prevention activities are linearly associated with knowledge of the adverse health effects 
of malaria. 
 
Scale-up of IPTp continues to be a challenge in Nigeria. According to the 2008 DHS, 
only 58% of pregnant women had access to antenatal care from a skilled provider, 62% 
of pregnant women delivered at home, and only 5% of pregnant women received two or 
more doses of IPTp (PMI 2010:5, 6). 
 
It is therefore imperative to assess the knowledge and use of IPT among the pregnant 
women in order to ensure sensitisation of pregnant women at health facility and 
community levels about the benefits of IPT for the women and their unborn babies.  
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1.4 AIM OF THE STUDY 
 
1.4.1 Research purpose 
 
The main purpose of the study was to assess the knowledge and use of IPT among 
pregnant women who attended ANC in the Health Centers of Federal Capital Territory. 
 
1.4.2 Research objectives 
 
The objectives of this research were to 
 
• determine the level of knowledge and use of IPT among pregnant women who 
attended ANC in health centers in Abuja, Nigeria 
• identify factors (socio-economic and cultural) that might influence IPT uptake 
among the pregnant women who attended ANC in health centers, in Abuja 
Nigeria 
 
1.4.2 Scope of the study 
 
This study was conducted in the selected health centers where antenatal services are 
rendered in the three area councils: Gwagwalada, Bwari and Amac in FCT. Pregnant 
women receiving ANC were given the questionnaires to fill.  
 
1.5  SIGNIFICANCE OF THE STUDY 
 
Obtaining information about the knowledge, use and practice of IPT in the population 
will help to strengthen malaria control strategies in FCT of Nigeria and the country as a 
whole. It is also expected that findings from this study would provide valuable 
information to guide educational material development for the IPT programme. 
 
Successful educational programmes would help women and their families to be well 
informed of malaria and its consequences during pregnancy and understand the need 
for use of IPT early in pregnancy and completing the recommended three doses. 
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The knowledge that would be imparted to the clients at the ANCs through educational 
talks and one-on-one counseling would go a long way in ensuring that these women 
adhere to their medications. With likely improved and adequate knowledge of the 
pregnant women about IPT, their acceptance of the programme may be greatly 
enhanced and thus they may be ready to participate in it to their full benefit. 
 
Finally, the research would help the scaling up of IPT in the areas where the knowledge 
and use have so far been limited. 
 
1.6 DEFINITIONS OF TERMS 
 
1.6.1 Knowledge 
 
The fact or condition of knowing something with familiarity gained through experience or 
association (Merriam-Webster English Dictionary 2011). 
 
Knowledge in the study is defined as having some understanding of malaria and its 
treatment, prevention, causative agent, sign, symptoms and mode of transmission.  
Level of knowledge would further be expressed in a form arbitrary scale ranging from 
low to high. 
 
1.6.2 Full dose of IPT during pregnancy 
 
Intermittent presumptive treatment (IPT) in pregnancy involves giving a curative 
treatment dose of an effective antimalarial drug at predefined intervals during pregnancy 
(White 2005:28). 
 
IPT is administered as a one-dose preventive treatment course after Quickening as 
Directly Observed Therapy (DOT) and the second dose is given not earlier than one 
month after the first dose (FMOH 2011:23). 
 
1.7 FOUNDATIONS OF THE STUDY 
 
The following flow chart (figure 1.1) attempts to describe the typical pattern of IPT 
provision for pregnant women in the study population. 
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Figure 1.1   Typical pattern of IPT provision for pregnant women 
 
According to the figure 1.1, when pregnant women register for ANC, some of them opt-
out from attending visit for ANC due to certain factors such as distance from health 
centers, migration, and literacy level while those who continue with ANC are given IPT 
alongside other routine services and advised by the ANC staff on the need for drug 
adherence. However, some of the pregnant women are compliant while some are non-
compliant due to the reasons given above. 
 
1.8 RESEARCH DESIGN AND METHOD 
 
Research design is an overall blueprint for implementing a particular study including 
specifications for enhancing the internal and external validity of the study (Grove, Burns 
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& Gray 2012:211). It guides the researcher in planning and implementing the study in a 
way that is most likely to achieve the intended goal, objectives and answers to the 
research questions (Grove et al 2012:211). A descriptive cross sectional study was 
conducted to measure knowledge and use of IPT among pregnant women attending 
ANC in health centers located in the FCT in Nigeria. A descriptive research provides 
an accurate account of the characteristics of a particular individual, event or group in 
real-life situations for the purpose of discovering new meaning, describing what exists, 
determining the frequency with which something occurs and categorising information 
(Grove et al 2012:734). In this type of research study, either the entire population or a 
subset thereof is selected, and from these individuals, data are collected to help answer 
research questions of interest.  
 
The study population comprised of all consenting pregnant women between the ages of 
18-49 years attending ANC at the selected health centers in the three area councils of 
the FCT. 
 
A multi-stage probability (random) sampling technique was used to select the health 
centers and participating pregnant women. Detailed description of this procedure is 
shown in chapter 3. Data was collected using a structured interview questionnaire. The 
Statistical Package for Social Sciences (SPSS) 22.0 was used to analyse the data. All 
returned questionnaires were coded into the computer for easy entry and analysis was 
performed by a statistician. This was used to manage data in order to gain frequencies 
and cross tabulations from the data. Data capturing was numerical and numbers were 
linked to questions asked in the questionnaire. Reliability and validity were ensured as 
presented in chapter 3. 
 
1.9 SCOPE OF THE STUDY 
 
This study was conducted in the selected health centers where antenatal services are 
rendered in the three area councils: Gwagwalada, Bwari and Amac in FCT pregnant 
women receiving ANC were given the questionnaires to fill.  
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1.10 STRUCTURE OF THE DISSERTATION 
 
Chapter one has presented the background information to the study, the problem 
statement, purpose, significance of the study, definitions of terms, research design, 
method and structure of the dissertation. Chapter 2 provides a background existing 
literature on Malaria, its prevalence, complications, clinical features, as well as coverage 
of IPT in Nigeria.  Chapter 3 discusses the overall plan and research procedures such 
as population and sampling technique, choice of sample size, data collection and data 
analysis method, ensuring validity and reliability and ethical considerations for 
addressing the research questions and objectives. Chapter 4 highlights the results, 
analysis and findings. Chapter 5 presents the discussions, conclusions and 
recommendations based on the research findings. See table 1.1 below. 
 
Table 1.1 Structure of the dissertation 
 
Chapter Title Content description 
1 Orientation to the study Overview of the research problem, purpose, 
significance of the study, definitions of terms, 
research design, methods and structure of the 
dissertation. 
2 Literature review An in depth review of the literature related to the 
topic under investigation to give the researcher an 
overview on what is published or discussed in the 
empirical literature about the phenomenon 
3 Research design and 
method 
The overall plan and research procedures such as 
population and sampling technique, choice of 
sample size, data collection and data analysis 
method, ensuring validity and reliability and ethical 
considerations for addressing the research 
questions and objectives 
4 Data presentation, analysis 
and interpretations 
Presentation, analysis and interpretation of the 
research findings 
5 Conclusions and 
recommendations 
Discussions, conclusions and recommendations 
based on the research findings 
 
1.11 CONCLUSION 
 
In this chapter, a brief outline of the steps that have been taken to conduct this study is 
presented. An introduction to the background to the research problem in relation to the 
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knowledge and use of IPT has been described. The research purpose and objectives, 
definition of the key terms and the significance of the study have been discussed.  
 
The chapter concludes with a brief introduction of the research design, methods used in 
the study and structure of the dissertation. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
Stommel and Wills (2004:339) define a literature review as a written summary and 
evaluation of the information gleaned from literature searches. It is an organised written 
presentation of what has been published on a topic by scholars. The purpose of the 
review is to convey to the reader what is currently known regarding the topic of interest 
(Grove et al 2012:93). Mouton (2001:87) states that a review of existing literature is 
important to 
 
• ensure that previous studies are not duplicated 
• discover the most recent and authoritative theory on the subject 
• find out the most widely accepted empirical findings in the field of study 
• identify available instrumentation that has proven validity and reliability 
 
The literature review in this study was conducted on malaria and its transmission, 
malaria in pregnancy, the situation of malaria in pregnancy in Nigeria, malaria 
complications, status of malaria prevention in Nigeria.   
 
2.2 MALARIA AND ITS TRANSMISSION 
 
Malaria remains an important public health problem worldwide especially in the tropics 
and it is an important cause of morbidity in pregnancy. In Nigeria, it is a leading cause of 
outpatient clinic consultation and is among the three common causes of death in Nigeria 
(Igunma, Ezeanochie & Hayes 2010:14). 
 
Malaria is caused by Plasmodium parasites, there are 5 parasite species that cause 
malaria in humans, and 2 of these species – P. falciparum and P. vivax pose the 
greatest threat (WHO 2015). 
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Each year, 25-30 million women become pregnant in malaria endemic area of Africa, 
and similar numbers are exposed to malaria in Asia, Oceania, and South America 
(Chukwuocha et al 2012:147). 
 
In the United States, malaria was eradicated in the 1940s after widespread spraying of 
dichlorodiphenyltrichloroethane (DDT) in the South. Other areas of the world including 
Europe and parts of Central and South America, have also had success in eradicating 
malaria (Schantz-Dunn & Nour 2009:188). 
 
Malaria is transmitted among humans by female mosquitoes of the genus Anopheles 
(CDC 2015a).  
 
Although all plasmodium species can affect maternal and foetal health, plasmodium 
falciparum infection is associated with the most severe effects and has been linked to 
increased maternal, foetal and neonatal morbidity and mortality (Manyando, Kayentao, 
D’Alessandro,Okafor, Juma & Hamed 2012:1). 
 
Falciparum malaria is an important cause of maternal anaemia, intra-uterine growth 
retardation, intrauterine death, stillbirth, premature delivery, low birth weight (LBW), 
perinatal and neonatal morbidity and mortality and postpartum morbidity (Vallely, 
Vallely, Changalucha, Greenwood & Chandramohan 2007:1). 
 
In pregnancy, there is a transient depression of cell-mediated immunity that allows 
foetal allograft retention but also interferes with resistance to various infectious 
diseases. Cellular immune responses to p. falciparum antigens are depressed in 
pregnant women in comparison with non-pregnant control women (Bouyou-Akotet, 
Lonete-Collard, Mabika-Manfoumbi, Kendjo, Matsiegui, Mavoungou, Kombila 2013:2).  
 
2.2.1 Population and climate profile of study area in relation to malaria 
transmission 
 
Temperature, rainfall and humidity have been associated with the dynamics of malaria 
vector populations and, therefore, with spread of the disease. Especially, ambient 
temperature plays a major role in the life cycle of the malaria vector. Rainfall provides 
breeding sites for mosquitoes to lay their eggs, and ensures a suitable relative humidity 
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of at least 50 to 60% to prolong mosquito survival (Alemu, Abebe, Tsegaye & Golassa 
2011:2). 
 
Rain pools and domestic containers constitute the most active anopheline breeding 
habitats in the wet season. However, in the dry season, significantly higher numbers of 
anophelines bred in lakes and swamps. The densities of anopheline larvae, in the 
breeding habitats, increased during the wet season and decreased in the dry season 
but the timing of peak densities was variable among habitat types (Olayemi, Ande, 
Ayanwale, Mohammed, Bello, Idris, Isah, Chukwuemeka & Ukubuiwe 2011:294). 
 
The FCT experiences two weather conditions in the year. These are the rainy season 
which begins around March and runs through October, the dry season (usually 
characterised by bright sunshine) which begins from October and ends in March. Within 
these periods, there is a brief period of harmattan occasioned by the North- East trade 
wind, with a resultant dusty haze and intense coldness and dryness. Nevertheless, the 
high altitude and undulating terrain of the FCT act as a modulating influence which 
makes the weather always clement (FCDA 2012:3). 
 
2.3 MALARIA AND PREGNANCY 
 
In areas of endemic malaria, it is estimated that at least 25% of pregnant women are 
infected with malaria, with the highest risk for infection and morbidity in primigravidas, 
adolescents, and those co-infected with HIV. The second trimester appears to bring the 
highest rate of infection, supporting the need for antepartum care as part of malarial 
prevention and treatment efforts. It is hypothesised that the majority of sequelae in 
pregnancy results from 2 main factors: the immune-compromised state of pregnancy 
and placental sequestration of infected erythrocytes (Schantz & Nour 2009:189). 
 
The serious consequences of malaria in pregnancy are attributed to the sequestration of 
malaria parasites in the placenta, leading to impeded trans-placental nutrient transport. 
This combined with malaria-induced anaemia, compromises foetal growth and results in 
low birth weight and a subsequent increase in infant and childhood mortality (Mbonye, 
Neema & Magnussen 2005:17). 
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HIV can infect, disable and ultimately destroys CD4 cells + lymphocytes essential for 
the development of antimalarial antibodies. It has thus been hypothesised that HIV 
infection could increase the risk of concomitant malaria infection, parasitemia, morbidity 
and mortality (Samak 2004:68). 
 
2.3.1 Pathophysiology and clinical features of malaria during pregnancy 
 
The pathophysiology of malaria-associated anemia is multifactorial. The most likely 
mechanisms include (1) hemolysis or the direct destruction of parasitised red blood cells 
that occurs both intravascularly and by sequestration in the microcirculation, mainly in 
the spleen; (2) specific/nonspecific immune responses, whereby red cell survival is 
shortened; (3) nonspecific, defective red cell production, which depresses 
erythropoiesis, inhibits reticulocyte release, and prematurely destructs red cells during 
maturation in the bone marrow; and (4) hypersplenism associated with a reduction in all 
three blood cell series, that is, causing not only anemia but also thrombocytopenia and 
leucopenia (Uneke 2008:1). 
 
Uncomplicated malaria usually presents with fever and nonspecific symptoms, such as 
vomiting and/or diarrhoea, a clinical picture that resembles that of many other childhood 
infectious diseases. In adults, severe malaria caused by P. Falciparum infection is 
characterised by multi-organ damage, including renal failure. Malaria can interact with 
other infectious diseases to modify the susceptibility and/or severity of either disease. 
For example, solid evidence now indicates that infection with HIV increases the risk of 
uncomplicated and severe malaria, In pregnant women, malaria and infection with HIV 
interact to cause low birth weight, and HIV impairs the efficacy of drugs used for malaria 
prevention (Greenwood, Fidock, Kyle, Kappe, Alonso, Collins & Duffy 2008:1269). 
 
The severity of clinical manifestations is determined by the level of immunity before 
pregnancy, which depends on the intensity and stability of malaria transmission. In low 
and/or unstable transmission areas, the degree of acquired immunity of women prior to 
pregnancy is low, and both the mother and her foetus are at risk for the most severe 
consequences of the infection. Malaria infections are symptomatic, and the current 
strategy is to treat every malarial access effectively. In contrast, in areas of high malaria 
transmission (as in sub-Saharan Africa), women have acquired a protective immunity 
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prior to pregnancy. Malaria infections are generally asymptomatic and the strategy is 
based on the prevention of infections (Briand, Cottrell, Massougbodji & Cot 2007:2). 
 
2.4 THE SITUATION OF MALARIA IN PREGNANCY IN NIGERIA 
 
Malaria infection during pregnancy is a major public health problem in tropical and 
subtropical regions throughout the world, The burden of malaria infection during 
pregnancy is caused mainly by Plasmodium falciparum, the most common malaria 
species in Africa (Adefioye, Adeyeba, Hassan & Oyeniran 2007:43). 
 
Uneke (2008:1) stated that a number of factors influence the prevalence of placental 
malaria in pregnant women, including maternal age, gravidity, use of prophylaxis, 
nutrition, host genetics, and level of antiparasite immunity, as well as parasite genetics 
and transmission rates. 
 
Different studies have been carried out to determine the prevalence of malaria parasite 
in pregnancy.  
 
Adefioye et al (2007:43-45) carried out a study to examine malaria parasite infection in 
pregnant women in relation to their behaviour and social pattern of living as they affect 
their exposure to malaria parasite infection, the study subjects consisted of 250 
pregnant women who came for their ante-natal visit at Ladoke Akintola University of 
Technology Teaching Hospital, Osogbo between April-June, 2004. The women were of 
varying age ranging from 20-40 years and also of different status, the prevalence of 
malaria parasite in pregnant women according to age is as follows: Of the 250 samples 
examined, 180 (72%) had malaria parasite in their blood. The age group 36-39 years 
recorded the highest prevalence rate of 88.2%, followed by age group 32-35 years 76% 
prevalence rate. According to educational status of the women, the illiterate pregnant 
women have the highest prevalence rate of 78.3%. The least prevalence rate was 
recorded among educated patients (54.4%) with 550 mean parasite density. 
 
According to the study conducted by Bassey et al (2007:2-3) on the profile of malaria in 
pregnant women attending antenatal clinics in rural community in Nigeria, out of the 
1400 pregnant women they screened, 1035 (73.9%) had detectable p. falciparum in 
their peripheral blood sample. The highest malaria prevalence in their study was among 
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primigravidae (55.8%) followed by those having second pregnancy (28.9%) and 
multigravidae (15.3%) respectively. The prevalence of p. falciparum among pregnant 
women was highest in the first trimester 41.3%, and showed decline to 30.0% and 
28.7% in the second and third trimesters respectively. 
 
2.5 MALARIA COMPLICATIONS 
 
2.5.1 Effects of malaria on maternal health 
 
The severity of clinical manifestations is determined by the level of immunity before 
pregnancy, which depends on the intensity and stability of malaria transmission. In low 
and/or unstable transmission areas, the degree of acquired immunity of women prior to 
pregnancy is low, and both the mother and her foetus are at risk for the most severe 
consequences of the infection (Briand et al 2007:2). 
 
While for area of low, unstable and seasonal transmission, where women have little 
acquired immunity are generally believed to be much more likely to result in symptoms, 
severe disease, and death of the mother or fetus than in endemic Africa. 
 
According to Brabin, Wasame, Uddenfeldt-Wort, Dellicour, Hill and Gies (2008:7), 
maternal mortality is an important complication of malaria in pregnancy and in lower 
transmission settings may result directly from severe malaria, or in higher transmission 
areas, indirectly, from severe anaemia. 
 
Apart from anemia, malaria may contribute to maternal mortality by increasing the risk 
and severity of obstetric conditions such as pre-eclampsia/eclampsia and postpartum 
hemorrhage by as much as 50 percent (Uneke 2008:2). 
 
2.5.2 Effects of malaria on birth outcome 
 
For the fetus, severe maternal anemia may result in intrauterine growth retardation, still 
birth, and low birth weight (Uneke 2008:2). 
 
Malaria during pregnancy may also influence the development of antimalarial immunity 
during the first years of life. Infants born to placenta-infected mothers were shown to be 
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more likely to develop a malaria infection between four and six months of life, compared 
to those born to non-infected mothers (Briand et al 2007:2). 
 
2.6 STATUS OF MALARIA PREVENTION IN NIGERIA 
 
Nigeria has been involved in several initiatives aimed at mitigating the impact of malaria 
for decades. In 1997, Nigeria adopted a National Malaria Control Policy in response to 
the government’s growing concern about the increasing burden of disease and death 
due to malaria. Malaria control and prevention in Nigeria was given more prominence 
following the launching of Roll Back Malaria (RBM) in 1998. RBM is a global movement 
geared towards bringing about a significant reduction of the malaria burden with special 
focus on the high transmission areas of Africa (FMOH 2008:16). 
 
The National Malaria Control Committee was set up in 1975 with membership drawn 
from the Federal and State Ministries of Health and the universities. In 1988 with the 
adoption of health systems reforms, malaria control fell within the concept of primary 
health care (NETMARK 2000:12). 
 
Apart from the RBM program, other initiatives have also been launched and some 
donors and some non-governmental organisations have come together to help control 
Malaria in Nigeria. 
 
The President’s Malaria Initiative (PMI) is a core component of the Global Health 
Initiative (GHI), along with HIV/AIDS, and tuberculosis. The PMI was launched in June 
2005 as a 5-year, $1.2 billion initiative to rapidly scale up malaria prevention and 
treatment interventions and reduce malaria-related mortality by 50% in 15 high-burden 
countries in sub-Saharan Africa. With passage of the 2008 Lantos-Hyde Act, funding for 
PMI has now been extended through FY2014 and, as part of the GHI, the goal of PMI 
has been adjusted to reduce malaria-related mortality by 70% in the original 15 
countries by the end of 2015 (PMI 2011:8). 
 
In 2005, Nigeria adopted the policy of IPT with SP which has been recommended by the 
World Health Organisation since 2000 (Igboeli, Adibe & Aguwa 2014:906). 
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Over the last few years, National Malaria Control Programme (NMCP) promoted IPT 
during pregnancy and supplied IPT drugs to the states. The programme also trained 
health workers on IPT as part of the training on malaria in pregnancy in all of the states. 
The NMCP and RBM partners supported states to introduce Artemisinin-based 
Combination Therapy (ACT) as the drug of choice and provided guidelines, training of 
health care providers, and drugs for treatment of childhood malaria (NMCP 2010:14). 
 
Current IPTp guidelines stipulate that all pregnant women in areas of stable malaria 
transmission should receive at least two doses of intermittent preventive treatment after 
quickening. As the current practice of focused antenatal care recommends at least four 
antenatal visits, it is envisaged that a high proportion of women can receive at least two 
doses of IPTp (Thiam, Kimotho & Gatonga 2013:1).  
 
IPT provides significant protection against maternal anemia and low birth weight, and 
reduces significantly the risk of abortion, still birth, pre-term deliveries and maternal 
mortality (Arulogun & Okereke 2012:416). 
 
Because of the poor compliance of women and the increasing rates of P. falciparum 
resistance to chloroquine the world health organisation changed its recommendation to 
IPT (Denoeud, Fievet, Aubouy, Ayemonna, Kiniffo, Massougbodji & Cot 2007:2).  
 
As part of antenatal care services, WHO recommends a schedule of at least four 
antenatal care visits during pregnancy, starting as early as possible in the second 
trimester, IPTp-SP is recommended for all pregnant women at each scheduled ANC 
visit until the time of delivery, provided that the doses are given at least one month 
apart. 
 
SP should not be given during the first trimester of pregnancy; however, the last dose of 
IPTp-SP can be administered up to the time of delivery without safety concerns IPTp-
SP should ideally be administered as directly observed therapy of three tablets 
sulfadoxine/pyrimethamine (each tablet containing 500 mg/25 mg SP) giving the total 
required dosage of 1500 mg/75 mg SP (WHO 2013:2). 
 
Despite the known side effects associated with sulfonamides, SP for intermittent 
preventive treatment in pregnancy is generally very well tolerated. Mild and transient 
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side effects including nausea, vomiting, weakness and dizziness have been reported by 
some women, particularly with the first dose of SP. Studies have demonstrated that side 
effects tend to decrease with the administration of further doses (WHO 2013:2). 
 
The results from the study by (Aduloju 2013:13) showed that IPT of malaria during 
pregnancy with SP is beneficial in improving pregnancy outcome, and babies born to 
mothers who received intermittent preventive treatment of SP on the average weighed 
more than babies born to women who did not received the drug. They also had shorter 
duration of labour which reduced the length of time the babies had to be exposed to the 
stress of labour. 
 
The WHO reports that at the end of 2008, 35 of 45 sub-Saharan African countries had 
adopted IPTp as national policy (Onoka et al 2012:2). The uptake of IPT varies between 
countries. 
 
According to the national survey data by Ejik, Hill, Alegana, Kirui, Gething, Kuile and 
Snow (2011:194) on the coverage of malaria protection in pregnant women in sub-
saharan Africa, Eritrea, which has both Plasmodium vivax and P falciparum 
transmission, has kept the option of intermittent preventive treatment in its national 
policy, but to their knowledge, this has not been implemented and chloroquine 
prophylaxis is used. 
 
Despite a high level of correct ANC attendance in Gabon, the goal of 80% of women 
with 2-dose IPTp-SP during pregnancy has not yet been reached (Bouyou-Akotet et al 
2013:5). In a Ugandan study by Kiwuwa and Mufubenga (2008:5-6), the baseline survey 
confirms that ANC attendance and delivery of a full IPT regimen are sub-optimal. This 
results in limited access to information on malaria prevention in pregnancy, such as the 
benefits of IPT and ITNs. Given findings of this baseline study and others to come in 
Uganda, they concluded that it is important to identify strategies to increase IPTp-SP 
uptake in rural areas. To this end, the malaria control programme of the Ministry of 
Health, Uganda, designed a programme to strengthen the capacity of the district for 
improved ANC performance and hence IPT uptake. 
 
Therapeutic efficacy studies carried out in Burundi in 2000 – 01 illustrated a failure rate 
of 49 percent with SP when used for the treatment of uncomplicated malaria in Burundi. 
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As result, Burundi changed its first - line treatment for malaria from SP to an artemisinin-
based combination therapy in late 2003. At the same time, the Ministry of Public Health 
decided to discontinue IPTp with SP. Burundi’s malaria in pregnancy strategy currently 
focuses on prevention through increasing ownership and use of long-lasting insecticide- 
treated nets among pregnant women. 
 
Recent discussions in the country have considered reintroducing a strategy of IPTp; 
however, differing schools of thought appear to exist regarding the usefulness of SP for 
IPTp in light of the high levels of drug resistance observed for treatment in 2001. 
Although many stakeholders felt that IPTp should be reintroduced, a strong lobby of 
clinicians does not support using SP for IPTp (Shretta & Kwiecien 2010:2). 
 
Implementation of IPT in Nigeria is weak (President’s Malaria Initiative 2010:19). Both 
first and second dose coverage remains low being 8.0% and 4.6% respectively in 
Nigeria (Onoka et al 2012:2).  
 
SP is supposed to be administered under direct observation by a health worker, but the 
absence of clean water and cups at health facilities makes directly observed therapy 
difficult. In addition, there is inadequate awareness on the part of health workers and 
pregnant women about IPT and a need to improve the level of collaboration between 
the NMCP and the Reproductive Health programme in IPT implementation (President’s 
Malaria Initiative 2010:19). 
 
The Nigerian government promotes IPT for pregnant women; however, at the moment, 
not all states are distributing this intervention free-of-charge when women visit the ANC 
whilst pregnant (Mens et al 2011:1). 
 
Mens and colleagues also estimated in their study that the level of knowledge on use of 
IPT in the prevention of malaria during pregnancy remained very low. 
 
2.7 IMPACT OF MALARIA 
 
Malaria affects household welfare as a result of an increase in the cost of treatment and 
prevention of the disease and decline in productivity through lost time. It also affects the 
quality of labour, it can lead to absenteeism, and even though an acute malaria attack 
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might not prevent people from working, it may only reduce the quality or productivity or 
output. Absenteeism from work can lead to income losses, particularly in the informal 
sector, where income is largely dependent on the number of productive hours (Salihu & 
Sanni 2013:296). 
 
Malaria imposes substantial costs to both individuals and governments. Costs to 
individuals and their families include purchase of drugs for treating malaria at home; 
expenses for travel to, and treatment at, dispensaries and clinics; lost days of work; 
absence from school; expenses for preventive measures; expenses for burial in case of 
deaths. Costs to governments include maintenance, supply and staffing of health 
facilities; purchase of drugs and supplies; public health interventions against malaria, 
such as insecticide spraying or distribution of insecticide-treated bed nets; lost days of 
work with resulting loss of income; and lost opportunities for joint economic ventures 
and tourism. Direct costs (for example, illness, treatment, premature death) have been 
estimated to be at least US$ 12 billion per year. The cost in lost economic growth is 
many times more than that (CDC 2015b). Monetary loss due to malaria in Nigeria is 
estimated to be about 132 billion naira in terms of treatment cost, prevention and loss of 
man-hours (Salihu & Sanni 2013:295). 
 
Malaria might cause and perpetuate poverty at the household level in a number of direct 
and indirect ways. Households suffer significant costs when a household member is 
sick with malaria. The direct and indirect costs of malaria might be substantial, further 
impoverishing poor households. The cost of malaria to poor households can be 
especially severe when the sick individual is a productive member of the household, 
particularly the primary income-earner. Reduced productivity and time away from work 
reduce household income (Ricci 2012:6). 
 
2.8 CONCLUSION 
 
The chapter started with a brief introduction of literature review. The chapter also talks 
about malaria and its transmission, pathophysiology and clinical features of malaria 
during pregnancy, the situation of malaria in pregnancy in Nigeria, malaria 
complications and status of malaria prevention in Nigeria. 
 
The next chapter discusses the methodology of the research.  
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CHAPTER 3 
 
RESEARCH DESIGN AND METHODOLOGY 
 
3.1 INTRODUCTION 
 
Chapter 3 describes the research design and methodology used to assess the 
knowledge and use of IPT among pregnant women receiving antenatal care in health 
centers in Abuja, Nigeria.  
 
Research methods help us collect samples, data and find a solution to a problem. 
Particularly, scientific research methods call for explanations based on collected facts, 
measurements and observations and not on reasoning alone (Rajasekar, Philominathan 
& Chinnathambi 2013:4).  
 
3.2 RESEARCH DESIGN 
 
Research designs are types of inquiry within qualitative, quantitative, and mixed 
methods approaches that provide specific direction for procedures in a research 
(Creswell, Knight, Connely & Scott 2009:41).  
 
Research design is a comprehensive plan for data collection in an empirical research 
project. It is a “blueprint” for empirical research aimed at answering specific research 
questions or testing specific hypotheses, and must specify at least three processes: (1) 
the data collection process, (2) the instrument development process, and (3) the 
sampling process (Bhattacherjee 2012:35). 
 
3.2.1 Research paradigm 
 
Quantitative research is a formal, objective, systematic process to describe and test 
relationships and to examine cause-and-effect interactions between variables (Grove et 
al 2012:747).  
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Quantitative research was considered an appropriate approach and used in this study 
because the study aims to measure knowledge and test relationships among variables. 
The variables were operationalised (made measurable) to generate statistical 
(verifiable) evidence. The study complied with the characteristics of quantitative 
research in the following ways: 
 
• It focused on a limited number of pre-specified variables (knowledge, malaria and 
IPT). 
• A structured data collection instrument was used. 
• The objectivity was enhanced by using structured data collection instrument that 
consisted of pre-specified items and by conducting statistical analysis. 
• Quality control was imposed by piloting and the data collection instrument was 
tested for validity. 
• Data analysis was done numerically using statistical procedures (descriptive 
statistics). 
 
A descriptive cross sectional design using quantitative approach was used in this 
study. 
 
A descriptive research provides an accurate account of the characteristics of a 
particular individual, event or group in real-life situations for the purpose of discovering 
new meaning, describing what exists, determining the frequency with which something 
occurs and categorising information (Grove et al 2012:212). The typical descriptive 
design is important for acquiring knowledge in an area in which little research has been 
conducted (Grove et al 2012:233). Some descriptive studies use questionnaires to 
describe an identified area of concern.  
 
Descriptive research is directed at making careful observations and detailed 
documentation of a phenomenon of interest. These observations must be based on the 
scientific method (i.e., must be replicable, precise, etc.), and therefore, are more reliable 
than casual observations by untrained people (Bhattacherjee 2012:6). 
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Cross-sectional research design 
 
Cross sectional studies are generally quick, easy, and cheap to perform. They are often 
based on a questionnaire survey. There will be no loss to follow-up because participants 
are interviewed only once. However, a cross sectional study may be prone to non-
response bias if participants who consent to take part in the study differ from those who 
do not, resulting in a sample that is not representative of the population (Sedgwik 
2014:2).  
 
The main characteristics of a descriptive cross sectional design include: 
 
• Data is collected only once 
• Ability to measure prevalence 
• Multiple outcomes can be studied 
• Hypothesis for future research can be generated 
• It is quick to conduct and can study a large number of subjects and variables at 
little cost or effort (Sedgwik 2014:2) 
 
A cross-sectional survey of 300 consented pregnant women at primary health centers 
offering ANC in the FCT between July and August 2012 was done. A list of the health 
centers offering ANC was obtained from the Ministry of Health which contained the 12 
health centers. 
 
3.3 THE RESEARCH METHOD 
 
Research methods refer to the systematic procedure for carrying out research. It is the 
logical process which is followed during the application of scientific methods and 
techniques when a particular phenomenon is investigated (Polit & Beck 2008:765).  
 
This section briefly explains the study setting, population, the sampling and sampling 
technique, the approach to data collection, data analysis, validity and reliability as well 
as ethical considerations. 
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3.3.1 Research study setting 
 
Study setting is defined by Polit and Beck (2008:766) as the physical location and 
conditions in which data collection takes place in a study. The study setting in this 
research is the health centers offering ANC (under the midwives service scheme MSS) 
under three selected area councils Amac, Bwari and Gwagwalada (FCT MDG Baseline 
2009:1), in the federal capital city of Nigeria.  
 
Abuja is found on latitude 8° 25” and 9° 25” North of the Equator and longitude 6° 45” 
and 7° 45” East of the Greenwich. It is bordered to the North by Kaduna state, to the 
east by Nassarawa state, to the west by Niger state and to the south by Kogi state 
(Ujoh, Kwabe & Ifatimehin 2010:107).  
 
The FCT has a land mass of approximately 8000 square meters, of which the actual city 
occupies 250 square meters (Medugu 2009:5). Abuja has a moderate climatic condition, 
with a savanna type of vegetation. The population of the city was estimated at 660,634 
in 2005, with the Gwaris as the most dominant ethnic group. The city has six area 
councils: Abuja Municipal Area Council (AMAC), Kuje Area Council, Gwagwalada Area 
Council, Kwali Area Council, Abaji Area Council and Bwari Area Council (SERAC 
2006:10). 
 
The public health care system is divided into three tiers, each associated with one of the 
administrative levels of government: federal; state; and local government authority 
(LGA). The 774 LGAs are the constitutionally-designated provider of primary health 
care. However, they are the weakest arm of the health system. There are more than 
13,000 primary health care facilities nationwide with a population to health facility ratio 
of about 5,500 residents to one. In addition to the Federal Ministry of Health, another 
centrally-funded agency, the National Primary Health Care Development Agency 
(NPHCDA) has the mandate to support the promotion and implementation of high 
quality and sustainable primary health care. The federal budget covers tertiary care and 
disease control programs, including malaria control; state budgets pay for secondary 
care; and LGA budgets cover primary care. The amount of government spending on 
health and malaria is difficult to determine, as funding levels vary and actual spending 
does not always match the original budget. Health accounts have not yet been 
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established, but it is believed that less than 5% of the national budget is spent on 
health. The public health system in Nigeria is quite weak. Problems include: 
 
• Inadequate decentralisation of services where most PHC facilities offer only a 
limited package of services. 
• Weak referral linkages between the different levels of health care. 
• Weak logistics systems for commodities with as many as six separate vertical 
commodities management systems with little or no coordination between them. 
• Dilapidated health infrastructure with many buildings and equipment in need of 
repair and/or maintenance. 
• Weak institutional capacity with inadequate supervision of health services. 
(President’s Malaria Initiative 2010:11). 
 
3.3.2 Population 
 
A population can be defined as all people or items (unit of analysis) with the 
characteristics that one wishes to study. The unit of analysis may be a person, group, 
organisation, country, object, or any other entity that you wish to draw scientific 
inferences about (Bhattarcherjee 2012: 65). 
 
In this study, the population comprised of all consenting pregnant women attending 
antenatal care at the selected health centers rendering antenatal services in the three 
area councils of the FCT at the time of the study in Abuja.  
 
3.3.3 Sampling method 
 
Bhattarcherjee (2012:65) defined sampling as the statistical process of selecting a 
subset (called a sample”) of a population of interest for purposes of making 
observations and statistical inferences about that population. He also pointed out the 
importance of choosing a sample that is truly representative of the population so that 
the inferences derived from the sample can be generalised back to the population of 
interest. 
 
Onwuegbuzie and Collins (2007:281) also defined sampling as the process of selecting 
a portion, piece, or segment that is representative of a whole. 
  
33 
The source of data for the study included pregnant women between the ages of 15-49 
at the time of the study resident in FCT for over one year who voluntarily agreed to 
participate in the study. 
 
In this study, probability (random) sampling was used as follows: 
 
• The target and accessible population was identified. 
• A sampling frame was compiled by acquiring a list of the health centers in the 
FCT. 
• Health facilities offering antenatal services formed the sampling unit. 
• A multi-stage (probability) random sampling technique was then used to select 
the health centers that offer ANC services. 
• Random sampling technique was used to select the pregnant women that were 
given the questionnaires to fill. It was self-administered; however, some things 
were explained to some of the people who asked questions. 
 
A probability sampling method was possible because the target population was clearly 
defined. In other words, every element in the population was identified.  
 
A sample obtained using a probability sampling method is more likely to be 
representative of the population than a non-probability sample. All the pregnant women 
in the population have a chance to be represented in the sample. There is also less 
opportunity for a systematic bias and all these increases the validity of the study. 
 
In simple random sampling, the elements are selected at random from the sampling 
frame. Numbers can be assigned to each name in the sampling frame such as numbers 
assigned to medical records, organisational memberships and licenses. These numbers 
may then be selected randomly to obtain a sample. Selection with replacement provides 
exactly equal opportunity for each element to be selected. Simple random sampling is 
the most basic of the probability sampling methods. A sample obtained using a 
probability sampling method is more likely to be representative of the population than a 
non-probability sample. All the subsets of the population which may differ from one 
another but contribute to the parameters of the population have a chance to be 
represented in the sample. There is less opportunity for systematic bias as it leaves the 
selection to chance thereby increasing the study validity (Grove et al 2012::346). 
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Bhattacherjee (2012:67) also defined Simple random sampling as a technique where all 
possible subsets of a population (more accurately, of a sampling frame) are given an 
equal probability of being selected.  
 
Advantages of simple random sampling 
 
The advantages of simple random sampling technique include that it is: 
 
• Easy to assemble the sample. 
• Considered a fair way of selecting a sample from a given population since every 
member is given equal opportunities of being selected. 
• Very representative of the population. 
• Reasonable to make generalisations from the results (of a Simple Random 
Sampling) back to the population (Castillo 2009:45). 
 
Disadvantages of simple random sampling 
 
The disadvantages of simple random sampling technique include that it: 
 
• Needs a complete list of all the members of the population (Castillo 2009). 
• Is very difficult to achieve i.e. time, effort and money (McLeods 2014). 
 
3.3.4 Eligibility criteria and sample size estimation 
 
Selecting a sample that is representative of the general population is an important part 
of quantitative research. 
 
 A sample is a subset of the total population that is of interest for the study topic. This 
“total” population is called the target population, to which the results of the study can be 
generalised (Omair 2014:142). 
 
The sampling frame is an accessible section of the target population (usually a list with 
contact information) from where a sample can be drawn (Bhattacherjee 2012:66). He 
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also mentioned that sampling frames may not entirely be representative of the 
population at large, and if so, inferences derived by such a sample may not be 
generalisable to the population. 
 
Accessible population refers to the members of a target population, which are within the 
reach of the researcher (Japhet 2014:1). 
 
The eligibility criteria include a list of characteristics essential for membership or 
eligibility in the target population (Grove et al 2012:342, 753). 
 
In this study, the eligibility criteria were: 
 
• Health centers providing ANC services in the Federal Capital Territory (FCT), 
Nigeria. 
• Pregnant women between the ages of 15-49 years who are registered for ANC in 
those health centers. 
 
The above eligibility criterion defines the target population. 
 
The inclusion criteria were:  
 
• Pregnant women between the ages of 15-49 at the time of the study who consent 
to participate in the study. 
• Pregnant women who have been resident in FCT for over one year. 
 
The women voluntarily agreed to participate in the study. 
 
The inclusion criteria define the target population. The sampling frame included a list of 
a list of the health centers in the FCT. The accessible population included all individuals 
who conform to the inclusion criteria and were available for the study. 
 
The choice of sample size is as important because it also determines the extent to 
which the researcher can make statistical and/or analytic generalisations (Onwuegbuzie 
& Collins 2007:287). 
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The exclusion criteria were: 
 
• Pregnant women who might be deaf/dumb. 
• Pregnant women who were not within the age bracket specified. 
• Pregnant women who have been resident in the city for less than a year. 
• Pregnant women who did not give their consent. 
 
Sample size determination for the study used the formula for single population estimate 
which is stated as below: 
 
n = z2 (1-p) p 
d2 
 
Where: 
 
z = the standard normal deviate set at 1.96, which corresponds with the 95% 
confidence interval. 
 
p = estimate of the proportion to be measured in this case, which in this case is 
proportion of pregnant women who could correctly define the benefit of IPT. A reference 
point of 23.9% from the study by Akinleye et al (2009:5) was used to represent P. 
q= 1- p   
 
d = degree of accuracy set at 5%  
 
Therefore, n = (1.96)2 (0.239) (0.761)    
                        (0.05)2             
        n = 279. 
 
For easier computation of percentages in this study, a sample size of three hundred 
(300) was used. These were selected from the ANC attendees of the primary health 
centers rendering antenatal services in the local government areas using systematic 
sampling technique. The sample size was then distributed among the PHCs. Using the 
estimate of the average clinic attendance of the month prior to the study, a sampling 
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interval was determined for each PHC and systematic sampling was used to select the 
study subjects. 
 
3.3.5 Data collection 
 
Data collection is the process of identifying respondents and the precise, systematic 
gathering of information relevant to the research purpose, the specific objectives or 
research question of a study (Burns & Grove 2005:536). In this study, data was 
collected using a structured questionnaire with multiple-choice questions to assess their 
knowledge about malaria and IPT. 
  
3.3.5.1 Data collection instrument  
 
A multiple-choice questionnaire with some closed-ended questions was developed 
specifically for this study (see annexure 8).  
 
Bhattacherjee (2012:74) defined a questionnaire as a research instrument consisting of 
a set of questions (items) intended to capture responses from respondents in a 
standardised manner. Questions may be unstructured or structured. Unstructured 
questions ask respondents to provide a response in their own words, while structured 
questions ask respondents to select an answer from a given set of choices. 
 
The data collection instrument comprised of questions answered in a specified 
sequence with a well-designated response options. The questionnaire comprised of 
questions on socio-demographic characteristics, obstetric history, knowledge about 
malaria, antenatal care clinic use, IPT use and perception on the attitudes and level of 
quality services rendered by antenatal clinic staff. The questionnaire was pre-tested 
prior to use. 
 
Existing instrument was adapted into a new questionnaire with 35 multiple-choice 
questions based on the research questions, research objectives and literature review, 
questionnaires used by Akinleye et al (2009:8) was adopted as guidelines.  
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Content of the questionnaire 
 
The questionnaire had six major sections namely; section A: Relevant socio-
demographic information, Section B: Obstetric history, Section C: Basic knowledge 
about Malaria, Section D: History of malaria during pregnancy, Section E: Antenatal use 
by pregnant women and attitude of ANC staff, Section F: practise of IPT and ITN use. 
 
SECTION A: Relevant socio-demographic information 
 
This part of the questionnaire consists of questions on the demographic profile of the 
sample population which includes: Age, ethnic group, level of education, religion, marital 
status, occupation, monthly income, accessibility to ANC clinic, cost of transportation. 
 
SECTION B: Obstetric history 
 
Obstetric history addressed here included: present gestational age, how many 
deliveries ever had, how many pregnancies ever had. 
 
SECTION C: Basic knowledge about malaria 
 
The questionnaire consists of questions such as: Knowledge and attitude of pregnant 
women towards malaria in pregnancy: what is malaria, modes of transmission of 
malaria, effects of malaria in pregnancy. 
 
SECTION D: History of malaria during pregnancy 
 
In this section the questionnaire consists of questions on the history of malaria during 
pregnancy: if they have ever had malaria during pregnancy, what was the line of 
treatment. 
 
SECTION E: Antenatal use by pregnant women and attitude of ANC staff 
 
This part of the questionnaire consists of questions on antenatal use by pregnant 
women and attitude of antenatal staff. 
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SECTION F: Practice of IPT and ITN use 
 
Section F addressed questions on the practice of IPT and ITN use. 
 
3.3.5.2 Pilot study 
 
A pilot study is, “a small-scale test of the methods and procedures to be used on a 
larger scale, the fundamental purpose of conducting a pilot study is to examine the 
feasibility of an approach that is intended to ultimately be used in a larger scale study 
(Leon, Davis & Kraemer 2011:2). 
 
The research instrument was pre-tested on a small number of respondents who were 
comparable to the sample of correspondents but who were not part of the main study. 
This ensured that errors of whatever nature could be rectified immediately at little cost. 
After the necessary modifications had been made following the pilot study, the 
instrument was administered to the full sample. 
 
In this study, the research instrument was pre-tested using ten respondents from the 
primary health center, Karu, Abuja. Actual data were collected during the pilot study and 
analysed carefully to ascertain whether or not they answered the multiple questions as 
expected. The result of the pilot study was used to refine the research instrument before 
using it in the actual study. 
 
3.3.5.3 Data collection process 
 
Two research assistants were carefully selected and properly trained for the data 
collection. The research assistants were members of the National Youth Service Corps 
(NYSC) and a nurse working at the Karu primary health center. The research assistants 
were trained in the handling of questionnaires (filling them in, answering the multiple 
choice questions, distribution and collection). Ethical issues such as informed consent, 
confidentiality, anonymity and respect were emphasised. The informed written consent 
(see annexure 7) was obtained from the respondents before completing the 
questionnaire (annexure 8). A clear explanation about the study, its goal and benefit 
was given. The completed instruments were checked at the end of each day for 
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omissions, incomplete answers and unclear statements. Data was collected for a period 
of two weeks. The questionnaires were collected immediately after completion.  
 
3.4 VALIDITY AND RELIABILITY 
 
Validity and reliability are critical aspects in research since they affect all processes 
leading to the credibility of research findings. They are important criteria to evaluate a 
research instrument in terms of its adequacy and quality. 
 
3.4.1 Validity  
 
Validity is defined as the degree to which an instrument measures what we intend to 
measure (Kimberly & Winterstein 2008:2278; Roach 2006).  
 
In this study, the validity of the questionnaire was assured by using questions from 
various instruments that had been used in other similar studies to formulate the multiple 
choice questions. 
 
3.4.1.1 Face validity 
 
Face validity refers to the degree to which a questionnaire or test appears to be 
measuring what it is supposed to measure (Alumran, Hou, Sun, Yousef & Hurst 
2014:2). Face validity means that an instrument empirically appears to measure what it 
is supposed to measure at face value (Polit & Beck 2008:458). 
 
In this study, face validity was ensured by careful selection of items to be included in the 
questionnaire. These items reflected the concept of knowledge about malaria and its 
prevention.  
 
3.4.1.2 Content validity 
 
Content validity is defined as the degree to which the items in an instrument adequately 
represent the universe of content for the concept investigated. Content validity deals 
with the question of how representative or adequate the compiled multiple choice 
questions are for the construct being measured (Alumran et al 2014:3). This was 
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ensured by the assistance of the study supervisor and the statistician. They read the 
content of the questionnaire and made their comments. Their suggestions were 
implemented where appropriate to make the content as valid as possible.  
 
3.4.1.3 Construct validity 
 
Construct validity is the extent to which an instrument measures the construct that it is 
intended to measure.  Construct validity is achieved when the tool: (1) measures the 
differences between contrasting groups of participants, (2) reflects the framework 
hypothesised in a hypothesis testing study, and (3) can undergo a confirmatory factor 
analysis which adequately establishes that the measurement model fits the actual data 
(Alumran et al 2014:2). 
 
Construct validity examines how well a given measurement scale is measuring the 
theoretical construct that it is expected to measure. (Bhattacherjee 2012:38). 
 
Construct validity according to Kimberly and Winterstein (2008:2279) is a judgment 
based on the accumulation of evidence from numerous studies using a specific 
measuring instrument. Evaluation of construct validity requires examining the 
relationship of the measure being evaluated with variables known to be related or 
theoretically related to the construct measured by the instrument. For example, a 
measure of quality of life would be expected to result in lower scores for chronically ill 
patients than for healthy college students. 
 
In more recent studies, construct validity has also included whether the scores serve a 
useful purpose and have positive consequences when they are used in practice 
(Creswell et al 2009:149). 
 
3.4.1.4 External validity 
 
This is defined by Polit and Beck (2008:753) as the degree to which study results can 
be generalised to settings or samples other than the one studied. This has implications 
for selection of respondents, which should be representative of the study population. 
The findings in this study may be a proxy to the practice of IPT in health centres in other 
parts of the country. This study is quantitative in nature hence it can be generalisable. 
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3.4.2 Reliability  
 
Reliability is defined as the extent to which a measurement is consistent and free from 
error. ‘Consistency’ means that the outcome measure will produce the same results on 
two or more occasions in a cohort whose status has not changed. ‘Free from error’ 
means that when a reliable outcome measure detects differences in patients over two 
more occasions, this is a result of a change in physical performance rather than 
measurement error (Bialocerkowski & Bragge 2008:422). 
 
Reliability estimates are used to evaluate (1) the stability of measures administered at 
different times to the same individuals or using the same standard (test-retest reliability) 
or (2) the equivalence of sets of items from the same test (internal consistency) or of 
different observers scoring a behavior or event using the same instrument (interrater 
reliability). Reliability coefficients range from 0.00 to 1.00, with higher coefficients 
indicating higher levels of reliability. Reliability is determined by the correlation of the 
scores from two or more independent raters (for ratings on a continuum) or the 
coefficient of agreement of the judgments of the raters (Kimberly & Winterstein 
2008:2277, 2278). 
 
A pilot study, using respondents with similar characteristics to the study sample, was 
conducted to improve clarity of questions and consistency of responses.  
 
3.5 DATA ANALYSIS 
 
Data analysis is the process of systematically applying statistical and/or logical 
techniques to describe and illustrate, condense and recap, and evaluate data 
(Responsible Conduct in Data Management 2009). 
 
Data preparation involves checking or logging the data into the computer. Data is also 
checked for accuracy and transformed. A database structure that integrates the various 
measures is developed and documented. With the help of a statistician, the SPSS 
version 22 was used for data entry and analysis. A mark sheet was used to assess the 
responses and to obtain scores of each respondent. 
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Descriptive statistics, frequency tables and percentages, pie charts were used in the 
data analysis and interpretation.  
 
In this study, the researcher behaved ethically in line with the purpose of the research 
discipline and public health profession. The research was conducted according to 
acceptable ethical standards and without any deception. Plagiarism was avoided as all 
sources and references cited were acknowledged. The data was analysed and 
interpreted according to methodological standards and was not biased because of the 
researcher’s opinion. The study includes presentation on measurement errors, 
limitations or shortcomings clearly. As part of the study, individuals or groups or 
institutions which contributed towards the successful accomplishment of the research 
process were duly acknowledged. 
 
3.6 ETHICAL CONSIDERATIONS 
 
Research ethics involves protecting the rights of the participants and the institutions in 
which the research is done, as well as maintaining scientific integrity (Grove et al 
2012:207). The study does not have either physical or psychological risks. The 
discomfort may just be mere inconvenience in terms of time. 
 
Research ethics in the study was adequately covered as follows: 
 
• Protecting the rights of the respondents 
• Voluntary participation  
 
In this research, participants were not  required to be involved without their willingness 
and  the researcher will ensured and let the participants know that it was their right to 
withdraw at any time during the interview. Participants were assured that withdrawal 
from the study at any time would not have any consequences on them. Their written 
consent was taken for those who were willing to participate in the study. 
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Informed consent 
 
Informed consent was obtained from the respondents. 
 
Informed consent form clearly describes their right to not participate and right to 
withdraw, before their responses in the study can be recorded. In a medical study, this 
form must also specify any possible risks to subjects from their participation 
(Bhattacherjee 2012:138). 
 
Informed consent means participants have adequate information about the research, 
comprehend that information, and have the ability to consent to or decline participation 
voluntarily (Polit & Beck 2012:157). 
 
Informed consent is considered the most important of all ethical principles and it is 
prominent in federal regulations regarding social research. According to Helsinki 
Declaration, in any research on human beings, each potential subject must be 
adequately informed of the aims, methods, sources of funding, any possible conflicts of 
interest, institutional affiliations of the researcher, the anticipated benefits and potential 
risks of the study and the discomfort it may entail (Udo-Akang 2013:55). 
 
In this research, the participants were informed on the full procedure of the research 
including the estimated time expected for the interview, about the selection procedure 
and number of research participants required, informing them the purpose and use of 
the data collected for research, and were assured that their participation in the study will 
not endanger their attendance at the health facility. 
 
Right to anonymity and confidentiality 
 
Anonymity, the most secure means of protecting confidentiality, occurs when the 
researcher cannot link participants to their data. A promise of confidentiality is a pledge 
that any information participants provide will not be publicly reported in a manner that 
identifies them, and will not be accessible to others (Polit & Beck 2012:162). 
 
Bharttacherjee (2012:138) stated that to protect subjects’ interests and future well-
being, their identity must be protected in a scientific study. This is done using the dual 
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principles of anonymity and confidentiality. Anonymity implies that the researcher or 
readers of the final research report or paper cannot identify a given response with a 
specific respondent. Further, anonymity assures that subjects are insulated from law 
enforcement or other authorities who may have an interest in identifying and tracking 
such subjects in the future. 
 
To ensure confidentiality, in this research, no name will be asked and written on the 
questionnaire during interview (It will be anonymous). Numerical coding will be used for 
identification on the questionnaire. Additionally, privacy will be ensured by conducting 
the interview in a communally conducive environment. 
 
• Right to fair treatment (based on ethical principle of justice): Subject to the 
maintenance of confidentiality in respect of individuals, all participants were fully 
informed about what the research was all about. Also, during the research, the 
researcher was at all times respecting the rights, wishes, beliefs, consent and 
freedom of the individual participants. 
• Right to protection from discomfort and harm: The ethical principle of 
beneficence refers to the Hippocratic "be of benefit, do not harm. Discomfort and 
harm can be physiological, emotional, social and economic in nature". A 
researcher must consider all possible consequences of the research and balance 
the risks with proportionate benefit. The type, degree, and number of potential 
risks must be assessed as well as the patients’ value system which ranks various 
harms. The risk benefit ratio can only be achieved by identifying these factors. If 
the risks outweigh the benefits, the study should be revised (Fouka & Mantzorou) 
2011:5-6). 
 
Respondents were protected from any form of harm/ discomfort which may be 
physiological, emotional, social or economic in nature. Benefit-risk ratio was maintained 
maximising the benefits and minimising the risks. 
 
Protecting the rights of the institution 
 
For conducting this research, ethical clearance will be sought from Research and Ethics 
Committee department of Health Studies, UNISA. Ethical clearance certificate regarding 
this study will be issued from UNISA (See Annexure 2) and the certificate will be taken 
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to Federal Capital Territory Health Research Ethics Committee (FCTHREC) together 
with my letter to ask for their permission to conduct the study. FCTHREC will then write 
a letter for permission to conduct the study in different health facilities (See Annexure 
4). Ethical clearance and the letter from FCTHREC will then be taken to different health 
facilities and then at facility level, permission will be sort from the head of the facility and 
then to the department of ANC within the facility. As the list of health facilities will be 
entered to the sampling frame, the name of the facility will be mentioned on the 
questionnaire at the time of data collection. 
 
Scientific integrity 
 
Ethics in research involves not only the protection of study subjects, but also protection 
of the public trust. Research misconduct is key factor that compromise scientific integrity 
of research. Research misconduct is defined as “fabrication, falsification, or plagiarism 
in proposing, performing, or reviewing research, or in reporting research results” (Polit & 
Beck 2012:169).  
 
3.7 CONCLUSION 
 
This chapter described the research design and methodology which included 
discussions on population, sampling and sampling technique, data collection, validity 
and reliability of the instrument, data analysis and ethical considerations. 
 
Chapter 4 discusses the data analysis and interpretation of the research findings.  
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CHAPTER 4 
 
DATA PRESENTATION, ANALYSIS AND INTERPRETATION 
 
4.1 INTRODUCTION 
 
This chapter is a summary of the findings obtained from the survey of health centres 
offering ANC (under the midwives service scheme MSS) under three selected area 
councils of Amac, Bwari and Gwagwalada (Federal Capital Territory Administration 
2015:6), in the Federal Capital City of Nigeria under the following headings:  
 
• socio-demographic characteristics of respondents 
• obstetric history 
• basic knowledge about malaria 
• source of information about malaria 
• practice regarding malaria prevention 
 
4.2 SECTION A: RELEVANT SOCIO DEMOGRAPHIC INFORMATION 
 
This section of the questionnaire covered the respondents’ age, ethnic group, marital 
status, highest school qualification, occupation, household monthly income and length 
of stay in Abuja. Though not central to the study, the personal data helped contextualise 
the findings and the formulation of appropriate recommendations for IPT among 
pregnant women. 
 
4.2.1 Age group 
 
The respondents were asked how old they were at their previous birthdays. Table 4.1 
depicts the respondents’ ages. 
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Table 4.1 Respondents’ age at the time of completing the questionnaires 
 
AGE GROUP FREQUENCY PERCENT 
15-20 34 11.3 
21-25 39 13.0 
26-30 93 31.0 
31-35 59 19.7 
36-40 65 21.7 
41-45 9 3.0 
46-49 1 0.3 
Total 300 100.0 
 
 
 
Figure 4.1   Respondents’ age at the time of completing the questionnaires 
 
The pregnant women’s ages ranged from 15 to 49, with the majority being 26-30 
(31.0%). This is within range but not exact with the study conducted in Tanzania by 
Gross, Alba, Schellenberg, Kessy, Mayumana and Obrist (2011:5) where the majority of 
the pregnant women in their study were within the age bracket of 20-24. 
 
About 11.0% of all births worldwide are by adolescents (15-19 years), in low and middle 
income countries, almost 10.0% of girls become mothers by age 16 years, with the 
highest rates in sub-Saharan Africa and south-central and south-eastern Asia. Coerced 
sex, reported by 10.0% of girls who first had sex before age 15 years, contributes to 
unwanted adolescent pregnancies (WHO 2015). However, there is a wide prevalence of 
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early marriages in Nigeria. Nationwide, 19.0% of girls were married by age 15 and 
43.0% by age 18 (Adebusoye 2006:7). 
 
4.2.2 Ethnic group 
 
Table 4.2 Respondents’ ethnic group 
 
ETHNIC GROUP FREQUENCY PERCENT 
YORUBA 25 8.3 
IGBO 30 10.0 
HAUSA 180 60.0 
OTHER 65 21.7 
TOTAL 300 100.0 
 
 
Figure 4.2   Respondents’ ethnic group 
 
The pregnant women are from Yoruba ethnic group, Igbo ethnic group, Hausa ethnic 
group or other ethnic group with majority being 180 (60.0%). It was therefore concluded 
that out of the 300 responses from the pregnant women, most pregnant women are 
from Hausa ethnic group. Therefore the research results might not be generalisable to 
pregnant women who are not from the Hausa ethnic group. It also indicates that most of 
the pregnant were from the Hausa ethnic group probably because the participating 
clinics were in areas where predominantly Hausa people live.  
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More Yoruba women were identified in this study which is similar to a study conducted 
in the western part of Nigeria (Ekiti state) by Aduloju, Ade-Ojo, Olaogun, Olofinbiyi and 
Akintayo (2013:11) that has reported more participants who were Yoruba (64.7%) which 
could be as a result of the location of the study. 
 
4.2.3 Marital status 
 
Table 4.3 Respondents’ marital status 
 
MARITAL STATUS FREQUENCY PERCENT 
SINGLE 103 34.3 
MARRIED 170 56.7 
DIVORCED 10 3.3 
WIDOWED 12 4.0 
SEPARATED 5 1.7 
TOTAL 300 100.0 
 
 
Figure 4.3   Respondents’ marital status 
 
The pregnant women are single, married, divorced, widowed or separated with majority 
being 170 (56.7%). It was therefore concluded that out of the 300 responses from the 
pregnant women, most pregnant women are married.  
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The study conducted by Igbodekwe, Oladimeji, Oladimeji, Adeoye, Akpa and Lawson 
(2014:76) indicated that married women have high frequency of sexual exposure and 
are more at risk of pregnancy than unmarried women which is in line with the results of 
this study. 
 
Gross et al (2011:5) also reported more of married women in their study (88%) as well 
as Bassey et al (2007:3) which is in line with this study findings. 
 
4.2.4 Education qualification (highest level of school attended) 
 
Table 4.4 Respondents’ educational qualification 
 
EDUCATION QUALIFICATION FREQUENCY PERCENT 
QURANIC SCHOOL 13 4.3 
PRIMARY SCHOOL 17 5.7 
SECONDARY SCHOOL 120 40.0 
UNIVERSITY 90 30.0 
OTHER 60 20.0 
TOTAL 300 100.0 
 
 
Figure 4.4  Respondents’ educational qualification 
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The pregnant women attended Quranic School, Primary School, Secondary School, 
University or other as highest level of school with majority being 120 (40.0%). The study 
results reflected that most pregnant women attended secondary school as their highest 
level of education which is 40.0%, this is not in accordance with the findings by Aduloju 
et al (2013:11) where majority of the participants in their study (62.0%) attained a 
tertiary education and not just secondary. 
 
In this study, having completed their schooling would have helped the women to know 
more about malaria, its effects on pregnancy and IPT. It would have also afforded the 
mothers more opportunities to continue with post-school education (university) or 
training and earn better salaries.  
 
The high literacy level seen in this study may be related to the location of the study area 
in Nigeria’s Federal Capital Territory with high population educated people. 
 
4.2.5 Occupation 
 
Table 4.5 Respondents’ occupation 
 
OCCUPATION FREQUENCY PERCENT 
SELF-EMPLOYED/OWN SMALL BUSINESS 54 18.0 
HOUSE WIFE 70 23.3 
FARMER 4 1.3 
TEACHER 23 7.7 
STUDENT 61 20.3 
UNEMPLOYED 40 13.3 
HEALTH PERSONNEL 8 2.7 
OTHER 40 13.3 
TOTAL 300 100.0 
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Figure 4.5  Respondents’ occupation 
 
The pregnant women were either self-employed/own small business, house wife, 
farmer, teacher, student, unemployed, health personnel or other. Of the respondents, 
70 (23.3%) were housewives. This agrees with the study by Bassey et al (2007:3) 
where majority of their participants (56.5%) were also unemployed. 
 
The above statistics suggest that most of the women (housewives) did not attain a 
university education and therefore did not have jobs. If they were employed, they might 
have been able to afford and opted for ANC in a private clinic. 
 
4.2.6 Average family income per month 
 
Table 4.6 Respondents’ average family income per month 
 
AVERAGE FAMILY INCOME PER MONTH FREQUENCY PERCENT 
(0-17,999) LOW INCOME 47 15.7 
(18,000-29,999) LOW INCOME 119 39.7 
(30,000-39,999) MIDDLE INCOME 54 18.0 
(40,000-99,999) HIGH INCOME 70 23.3 
(100,000 AND ABOVE) HIGH INCOME 10 3.3 
TOTAL 300 100.0 
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Figure 4.6  Respondents’ average family income per month 
 
The pregnant women’s average family income per month ranges from 0 to 100,000 
plus, with the majority being 119 (39.7%). The results showed most pregnant women 
are from low income families meaning that their average family income per month is at 
least 18,000 and at most 29,000 and probably would not be able to obtain a standard 
health care. This has been supported by Bassey et al (2007:3) study which has reported 
66.0% of their respondents were from low income homes. 
 
They may also find it difficult having enough funds for transport costs should the clinics 
not be within walking distance from their homes. 
 
4.2.7 Length of stay in Abuja 
 
Table 4.7 Respondents’ length of stay in Abuja 
 
LENGTH OF STAY IN ABUJA FREQUENCY PERCENT 
ONE YEAR - TWO YEARS 67 22.3 
THREE YEARS - FIVE YEARS 153 51.0 
MORE THAN FIVE YEARS 80 26.7 
TOTAL 300 100.0 
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Figure 4.7  Respondents’ length of stay in Abuja 
 
The pregnant women in this study have either lived in Abuja for (one years-two years), 
(three year-five years) or (more than five years). Of the respondents, 153 (51.0%) have 
lived in Abuja for a period of at least three to five years.  
 
Considering the length of stay in Abuja, this statistically suggests that most pregnant 
women will be able to locate places where they can and would be able to access health 
care facilities both within and outside their neighborhood. 
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4.3 SECTION B: OBSTETRIC HISTORY 
 
4.3.1 Number of months pregnant today 
 
Table 4.8 Respondents’ stage of pregnancy as at the time of survey 
 
NUMBER OF MONTHS PREGNANT FREQUENCY PERCENT 
3 MONTHS 46 15.3 
4 MONTHS 62 20.7 
5 MONTHS 77 25.7 
6 MONTHS 50 16.7 
7 MONTHS 26 8.7 
8 MONTHS 18 6.0 
9 MONTHS 21 7.0 
TOTAL 300 100.0 
 
 
Figure 4.8  Respondents’ stage of pregnancy as at the time of survey 
 
The number of months pregnant ranges from 3 months to 9 months with the majority 
being 77 (25.7%). It was therefore concluded that out of the 300 responses from the 
pregnant women, most pregnant women were 5 months pregnant. This is similar to the 
study by Akaba, Otubu, Agida and Onafowokan (2013:204) and also corroborates the 
fact that some of our pregnant women do not seek ANC care early in pregnancy. 
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Chikwasha et al (2014:16) in their study stated that both in the general Zimbabwe 
population and in the IPTp districts, the majority of pregnant women registered for the 
first time at ANC after the second and third trimester.  
 
World Health Organization recommends that pregnant women in developing countries 
should seek ANC within the first 4 months (17 weeks) of pregnancy, despite this WHO 
recommendation and the ANC policy in Nigeria, studies have shown that late booking 
has become a persistent pathology in the country similar to what is being reported for 
other developing countries of the world (Ifenne & Utoo 2012). 
 
4.3.2 How many child births have you ever had? 
 
Table 4.9 Number of children 
 
NUMBER OF CHILD BIRTH FREQUENCY PERCENT 
1 CHILD 72 24.0 
2 CHILDREN 90 30.0 
3 CHILDREN 82 27.3 
4 CHILDREN 56 18.7 
TOTAL 300 100.0 
 
 
Figure 4.9 Number of children 
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Of the respondents, majority 90 (30.0%) of the pregnant women have had two children. 
None of them was pregnant for the first time, in other words there was no primigravidae 
among them. This is similar to the study conducted by Enato, Okhamafe and Okpere 
(2007:34) where majority of their respondents were multigravidae. 
 
4.3.3 Number of pregnancies 
 
Table 4.10 Number of pregnancies 
 
NUMBER OF PREGNANCIES FREQUENCY PERCENT 
1ST PREGNANCY 0 0.0 
2ND PREGNANCY 72 24.0 
3RD PREGNANCY 90 30.0 
4TH PREGNANCY 82 27.3 
5TH PREGNANCY 56 18.7 
6TH PREGNANCY 0 0.0 
7TH PREGNANCY 0 0.0 
TOTAL 300 100.0 
 
 
Figure 4.10   Number of pregnancies 
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The response to the question ranges between 1st pregnancy and 7th pregnancy with the 
majority being 90 (30.0%) who were pregnant for the third time. This corroborates the 
fact that our pregnant women book late for antenatal clinic (Akaba et al 2013:204). 
 
4.4 SECTION C: BASIC KNOWLEDGE ABOUT MALARIA 
 
4.4.1 Have you ever heard of malaria? 
 
Table 4.11 Have you ever heard of malaria 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 8 2.7 
YES 267 89.0 
NO 25 8.3 
TOTAL 300 100.0 
 
 
Figure 4.11  Have you ever had malaria? 
 
The responses range from don’t know response, yes response or no response with the 
majority being 267 (89.0%) who know about malaria and its mode of transmission. 
Since most of them have a basic education, they already have an idea about malaria. 
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4.4.2 Which vector can transmit malaria to human beings 
 
The question above was asked to know how much they know about malaria 
transmission, and from their responses, they obviously have a good knowledge of what 
vector that transmits malaria even though a few of them did not provide answers. 
 
Table 4.12 Rats 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 0 0.0 
YES 0 0.0 
NO 282 94.0 
MISSING VALUE 18 6.0 
TOTAL 282 100.0 
 
Of the respondents, 282 (94.0%) said that rat was not a vector that transmits malaria, 
18 (6.0%) of the respondents did not answer this question. This shows that the 
respondents had a good knowledge of malaria transmission. In the study conducted by 
Thanabouassy (2008:45) 70.6% of their respondents answered that rat was one of the 
vectors which transmit malaria. 
 
4.4.3 Dogs 
 
Table 4.13 Dogs 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 0 0.0 
YES 0 0.0 
NO 300 100.0 
TOTAL 300 100.0 
 
All of the respondents 300 (100%) disagreed with dogs being a vector that transmits 
malaria. In the study conducted by Thanabouassy (2008:45) 71.3% of the participants 
agreed with dogs being vectors that transmit malaria which had reflected lack of 
knowledge with regard to malaria transmission as opposed to the findings of this study 
where all respondents disagreed that dogs transmit malaria. 
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4.4.4 Mosquitoes 
 
Table 4.14 Mosquitoes 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 0 0.0 
YES 300 100.0 
NO 0 0.0 
TOTAL 300 100.0 
 
This excellent knowledge of the cause of malaria among pregnant women confirms 
malaria as a common infection in Nigeria, All of the respondents 300 (100%) agreed 
with mosquitoes being a vector that transmits malaria. This is similar to the findings by 
Akaba et al (2013:203) where 92.6% of their respondents chose mosquito as a vector 
that transmits malaria. 
 
4.4.5 Houseflies 
 
Table 4.15 Houseflies 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 0 0.0 
YES 0 0.0 
NO 287 95.7 
MISSING VALUE 13 4.3 
TOTAL 287 100.0 
 
Of the respondents, 287 (95.7%) disagreed with housefly as a vector that transmits 
malaria. While 13 (4.3%) did not answer this question. 
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4.4.6 Cockroach 
 
Table 4.16 Cockroach 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 0 0 
YES 0 0 
NO 300 100 
TOTAL 300 100.0 
 
Of the respondents, 300 (100%) did not agree with cockroach being a vector that 
transmits malaria. 
 
4.4.7 Symptoms of malaria 
 
Respondents is this study were able to identify the main symptoms of malaria namely 
(fever, cold and headache), and this was comparable to the study by Thanabouasy 
(2008:46) where 94.8% identified fever as a symptom of malaria, 88.5% identified 
headache while 78.6% identified chill and Akaba et al (2013:203) where 79.2% of their 
respondents said that fever was a symptom of malaria and 65.5% said headache was a 
symptom. 
 
Table 4.17 Symptoms of malaria:  Fever 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 2 0.7 
YES 287 95.7 
NO 0 0.0 
MISSING VALUE 11 3.6 
TOTAL 300 100.0 
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Figure 4.12   Symptoms of malaria:  Fever 
 
Majority of the respondents 287 (95.7%) agree that fever is a symptom of malaria, 2 
(0.7%) said they did not know, 11 (3.6%) did not answer this question. 
 
4.4.8 Symptoms of malaria:  Headache 
 
Table 4.18 Symptoms of malaria:  Headache 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 5 1.7 
YES 283 94.3 
NO 12 4.0 
TOTAL 300 100.0 
 
0.7% 
95.7% 
0.0% 
3.6% 
DON'T KNOW
YES
NO
MISSING VALUE
  
64 
 
Figure 4.13   Symptoms of malaria:  Headache 
 
Of the respondents, 283 (94.3%) agree that headache is a symptom of malaria, 5 
(1.7%) do not know, 12 (4.0%) said no. 
 
Table 4.19 Symptoms of malaria:  Chill/Cold 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON’T KNOW 26 8.7 
YES 261 87.0 
NO 13 4.3 
TOTAL 300 100.0 
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Figure 4.14   Symptoms of malaria:  Chill/Cold 
 
Majority 261 (87.0%) of the respondents agree that chill/cold is a symptom of malaria. 
 
Table 4.20 Symptoms of malaria:  Itching 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 33 11.0 
YES 19 6.3 
NO 248 82.7 
TOTAL 300 100.0 
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Figure 4.15   Symptoms of malaria:  Itching 
 
Majority of the respondents 248 (82.7%) do not agree with itching being one of the 
symptoms of malaria. 
 
Table 4.21 Symptoms of malaria:  Sweating 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 90 30.0 
YES 100 33.3 
NO 110 36.7 
TOTAL 300 100.0 
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Figure 4.16  Symptoms of malaria:  Sweating 
 
Of the respondents, 110 (36.7%) answered no to sweating as one of the symptoms of 
malaria, 100 (33.3%) answered yes while 90 (30.0%) answered that they do not know. 
 
Table 4.22 Symptoms of malaria:  Stomach pain 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 123 41.0 
YES 77 25.7 
NO 100 33.3 
TOTAL 300 100.0 
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Figure 4.17   Symptoms of malaria:  Stomach pain 
 
Of the respondents, 123 (41.0%) do not know if stomach pain is a symptom of malaria, 
100 (33.3%) answered no while 77 (25.7%) answered no to this question. 
 
Table 4.23 Symptoms of malaria:  Vomiting 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 44 14.7 
YES 220 73.3 
NO 36 12.0 
TOTAL 300 100.0 
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Figure 4.18  Symptoms of malaria:  Vomiting 
 
Of the respondents, 220 (73.3%) (more than half) answered yes to vomiting being a 
symptom of malaria, 44 (14.7%) answered that they did not know (not sure), 36 (12.0%) 
answered no. This is also comparable to Thanabouassy (2008:44) where more than half 
of their respondents (61.8%) answered that vomiting is a symptom of malaria. Although 
the percentage of the women in this study (73.3%) who knew that vomiting is a 
symptom of malaria is higher than that in his study (61.8%). 
 
4.4.9 Ways to prevent and control malaria 
 
Their knowledge of prevention and control of malaria was also satisfactory. 
 
Table 4.24 Prevention of malaria:  Wearing of long sleeves 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 50 16.7 
YES 200 66.7 
NO 50 16.6 
TOTAL 300 100.0 
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Figure 4.19  Prevention of malaria:  Wearing of long sleeves 
 
The types of responses for wearing long sleeve clothes as a way of preventing malaria 
ranges from don’t know response, yes response or no response. Of the respondents, 
200 (66.7%) think that wearing a long sleeve clothe is way of preventing and control 
malaria. It could be deduced from their responses that because they believe that with 
the wearing of long sleeve clothes, less mosquitoes would bite them. The response rate 
is not at par with Astatkie (2010:189), in the study, the respondents were asked if 
wearing of protective clothes was one of the ways of preventing malaria, 6.4% 
answered yes. 
 
4.4.10 Prevention of malaria:  Using insecticides and treated nets (ITN) 
 
Table 4.25 Prevention of malaria:  Using insecticides and treated nets (ITN) 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 10 3.4 
YES 250 83.3 
NO 40 13.3 
TOTAL 300 100.0 
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Figure 4.20   Prevention of malaria:  Using insecticides and treated nets 
 
The types of responses for using insecticide treated net (ITN) for pregnant woman 
ranges from don’t know response, yes response or no response with the majority being 
250 (83.3%) who accepted using insecticide treated nets (ITN) as a way to prevent and 
control malaria. Free insecticide treated nets are being distributed in some hospitals by 
some non-governmental organisations. 
 
Many African countries including Nigeria are providing free ITN to children and pregnant 
women and subsidising the cost of ITN for other people. 
 
Their responses here were higher but also comparable to that gotten by Akaba et al 
(2013:203) where 74.9% of their respondents knew that the use of ITN was a way of 
preventing malaria. 
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4.4.11 Prevention of malaria:  Trimming bushes around the house 
 
Table 4.26 Prevention of malaria:  Trimming bushes around the house 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 50 16.7 
YES 225 75.0 
NO 25 8.3 
TOTAL 300 100.0 
 
 
Figure 4.21  Prevention of malaria:  Trimming bushes around the house 
 
The types of responses for trimming bushes around their houses ranges from don’t 
know response, yes response or no response with the majority being 225 (75.0%) who 
accept that trimming bushes around the house is a way to prevent and control malaria. 
This could also be prompted by the fact that there used to be compulsory monthly 
sanitation all over the country. 
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4.4.12 Prevention of malaria:  Taking malaria drugs before going to the forest 
 
Table 4.27 Prevention of malaria:  Taking malaria drugs before going to the 
forest 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 43 14.4 
YES 16 5.3 
NO 241 80.3 
TOTAL 300 100.0 
 
 
Figure 4.22   Prevention of malaria:  Taking malaria drugs before  
going to the forest 
 
Of the respondents, 241 (80.3%) do not accept taking malaria drugs before going to the 
forest as way to prevent and control malaria. Most of them are not farmers and as such 
do not have need to go to the forest. 
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4.4.13 Prevention of malaria:  Insecticide spray 
 
Table 4.28 Prevention of malaria:  Insecticide spray 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 19 6.3 
YES 261 87.0 
NO 20 6.7 
TOTAL 300 100.0 
 
 
Figure 4.23   Prevention of malaria:  Insecticide spray 
 
Of the respondents, 261 (87.0%) agree with the use of insecticide spray as way to 
prevent and control malaria. The response rate is not in agreement with that from the 
study by Astatkie (2010:190) where 24.0% of the respondents agreed that insecticide 
spray is one of the ways of preventing malaria. 
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4.4.14 Prevention of malaria:  Taking preventive drugs 
 
Table 4.29 Prevention of malaria: Taking preventive drugs 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 76 25.4 
YES 124 41.3 
NO 100 33.3 
TOTAL 300 100.0 
 
 
Figure 4.24   Prevention of malaria:  Taking preventive drugs 
 
Most of the respondents 124 (41.3%) agree that taking preventive drugs is a way to 
prevent and control malaria. The knowledge of the importance of prophylaxis for malaria 
prevention may be a function of the fact that they had benefited from IPT during 
previous pregnancies or the current pregnancy and they might have heard about it from 
other sources like television/radio commercials, posters, drug stores, etc. 
 
Most of the respondents had good knowledge of the malaria preventive practices in 
Nigeria such as ITN, IRS, trimming of bushes around the house and prohylaxis. This is 
also comparable to the study by Akaba et al (2013:203) where 74.9% of the 
respondents are aware that the use of ITN is a way of preventing malaria, 66.3% 
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agreed to keeping the environment tide, 53.1% agreed that taking preventive drugs 
(prophylaxis) is a way of preventing malaria. 
 
4.5 EFFECT OF MALARIA IN PREGNANCY 
  
Their responses here reveal that the level of knowledge regarding the effects of malaria 
in pregnancy is not adequate for these respondents. This was evidenced by the 
following results presented according to different sections from stillbirth to the last 
complication.  
 
Their knowledge of the effects of malaria in pregnancy can be compared to the study 
done in Benin City, Nigeria by Enato et al (2007:35) which indicates that knowledge of 
the consequences of malaria during pregnancy was poor among pregnant women. 
 
Although not comparable to the study done in Ebonyi state by Omaka-Omari and 
Nwimo (2015:168), their respondents had a high knowledge of the effects of malaria on 
pregnancy, their responses are as follows: Maternal anaemia 68.65%, low birth weight 
babies 72.62%, abortion 61.11%, death of the mother 64.88%. 
 
4.5.1 Effect of malaria in pregnancy:  Still birth 
 
Table 4.30 Effect of malaria in pregnancy:  Still birth 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 101 33.7 
YES 67 22.3 
NO 132 44.0 
TOTAL 300 100.0 
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Figure 4.25   Effect of malaria in pregnancy:  Still birth 
 
132 (44.0%) of the respondents, do not agree still birth is an effect of malaria in 
pregnancy. They probably do not have indebt knowledge of the effects of malaria in 
pregnancy.  
 
4.5.2 Effect of malaria in pregnancy: Low birth weight 
 
Table 4.31 Effect of malaria in pregnancy: Low birth weight 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 160 53.4 
YES 16 5.3 
NO 124 41.3 
TOTAL 300 100.0 
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Figure 4.26   Effect of malaria in pregnancy:  Low birth weight 
 
Majority of the respondents 160 (53.4%) are not aware if low birth weight is an effect of 
malaria in pregnancy. If some of these respondents had had a better education, they 
would have had a better knowledge. 
 
4.5.3 Effect of malaria in pregnancy: Maternal death 
 
Table 4.32 Effect of malaria in pregnancy: Maternal death 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 172 57.3 
YES 36 12.0 
NO 92 30.7 
TOTAL 300 100.0 
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Figure 4.27   Effect of malaria in pregnancy:  Maternal death 
 
Of the respondents (majority), 172 (57.3%) are not aware if maternal death is an effect 
of malaria in pregnancy. 
 
4.5.4 Effect of malaria in pregnancy: Abortion 
 
Table 4.33 Effect of malaria in pregnancy: Abortion 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 200 66.6 
YES 80 26.7 
NO 20 6.7 
TOTAL 300 100.0 
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Figure 4.28   Effect of malaria in pregnancy:  Abortion 
 
In this study 200 (66.6%) of the respondents are not aware whether abortion could be 
an effect of malaria in pregnancy. This is in contrast to the study done in Uganda by 
Obol, Lagoro and Garimoi (2011:5) where half of their respondents cited abortion as 
the consequences of malaria infection during pregnancy, Other consequences of 
malaria infection during pregnancy mentioned by their respondents were anaemia, 
transmission across to the foetus, premature delivery of babies, foetal death, death of 
the pregnant woman, and giving birth to a low weight baby.  
 
4.5.5 Effect of malaria in pregnancy: Tuberculosis 
 
Table 4.34 Effect of malaria in pregnancy: Tuberculosis 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 88 29.3 
YES 12 4.0 
NO 200 66.7 
TOTAL 300 100.0 
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Figure 4.29   Effect of malaria in pregnancy:  Tuberculosis 
 
Out of 300 respondents, 200 (66.7%) of the respondents do not agree that tuberculosis 
could be an effect of malaria in pregnancy.  
 
4.6 BREEDING SITE OF A MOSQUITO 
 
The respondents had good knowledge regarding breeding site of mosquitoes, this 
agrees with Omaka-Omari and Nwimo (2015:169) where their respondent's knowledge 
was high (69.87%) with respect to breeding sources.  
 
The responses from this study have been tabulated below:  
 
4.6.1 Breeding site for mosquitoes:  Pond or lake 
 
Table 4.35 Breeding site for mosquitoes:  Pond or lake 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 48 16.0 
YES 132 44.0 
NO 120 40.0 
TOTAL 300 100.0 
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Figure 4.30   Breeding site for mosquitoes:  Pond or lake 
 
Of the respondents, 132 (44.0%) of the respondents agree that pond or lake is breeding 
site of a mosquito.  The responses to all the options of the breeding site of a mosquito in 
this section show that the respondents are aware of how malaria is transmitted. 
 
4.6.2 Breeding site for mosquitoes:  Stagnant water 
 
Table 4.36 Breeding site for mosquitoes:  Stagnant water 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 10 3.4 
YES 280 93.3 
NO 10 3.3 
TOTAL 300 100.0 
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Figure 4.31   Breeding site for mosquitoes:  Stagnant water 
 
Of the respondents, 280 (93.3%) agree that stagnant water is a breeding site of a 
mosquito. This corresponds with the findings from the study by Omaka-Omari and 
Nwimo (2015:168) where 77.98% of their respondents agreed that stagnant water was 
a breeding site for mosquitoes. 
 
4.6.3 Breeding site for mosquitoes:  Canal 
 
Table 4.37 Breeding site for mosquitoes:  Canal 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 123 41.0 
YES 77 25.7 
NO 100 33.3 
TOTAL 300 100.0 
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Figure 4.32   Breeding site for mosquitoes:  Canal 
 
In this study 123 (41.0%) of the respondents are not aware whether canal is a breeding 
site of a mosquito. 
 
4.6.4 Breeding site for mosquitoes:  Dry and clean places 
 
Table 4.38 Breeding site for mosquitoes:  Dry and clean places 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
DON'T KNOW 10 3.3 
YES 20 6.7 
NO 270 90.0 
TOTAL 300 100.0 
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Figure 4.33   Breeding site for mosquitoes:  Dry and clean places 
 
Of the respondents, 270 (90.0%) do not agree that dry and clean places is a breeding 
site of a mosquito. According to a study conducted by Omaka-Omari and Nwimo 
(2015:168), 79.76% of the respondents agreed that mosquito breeds in dirty places 
which is different from this study finding. 
 
4.7 SECTION D: SOURCE OF INFORMATION ABOUT MALARIA 
 
4.7.1 Information regarding malaria 
 
All the 300 respondents answered yes to the question:  Have you heard any information 
about malaria? 
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Table 4.39  Sources of information about malaria 
 
SOURCE OF INFORMATION FREQUENCY PERCENT 
HOSPITAL 88 29.3 
HEALTH CENTER 35 11.7 
HOME (FAMILY MEMBER) 50 16.7 
COMMUNITY HEALTH LEADER 12 4.0 
NEIGHBOUR 4 1.3 
DRUG HAWKER 0 0.0 
RADIO OR TELEVISION 55 18.3 
OTHER (PLEASE SPECIFY) 18 6.0 
MISSING VALUE 38 12.7 
TOTAL 300 100.0 
 
 
 
Figure 4.34   Source of information about malaria 
 
Of the respondents, 46 (15.3%) did not answer this question, 88 (29.3%) heard about 
malaria at the hospital, 35 (11.7%) heard from the health center, 50 (16.7%) heard from 
a family member, 12 (4.0%) heard from a community health leader, 4 (1.3%) heard from 
neighbours, 55 (18.3%) heard from radio/television, 18 (6.0%) heard from other 
sources. 
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The responses above differ from that in the study by Astatkie (2010:189) where the 
following results were gathered: Health personnel 76.6%, radio 59.5%, television 
20.6%, friends/neighbours/relatives 12.0%, newspaper/magazines/posters/notice at a 
pharmacy 4.4%. While 38 (12.7%) did not answer this question. 
 
4.7.2 Responses about if health nurses do give talk about malaria 
 
Table 4.40 Do health nurses give talks about malaria 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
YES 37 12.3 
NO 263 87.7 
TOTAL 300 100.0 
 
 
Figure 4.35  Do health nurses give talks on malaria 
 
Of the respondents, 263 (87.7%) said that nurses do not give talks on malaria. 
 
This could be as a result of negligence on the part of the nurses or due to the fact that 
some of the respondents did not really take ANC visits seriously as a result may not 
know if the nurses actually gave talks on malaria or not. This is in contrast to a study 
done by Arulogun and Okereke (2012:420) in a hospital in South-west Nigeria, almost 
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all (94.3%) pregnant women they interviewed said that malaria was a topic often 
discussed during ante-natal health talks. 
 
4.8 PRACTICE REGARDING MALARIA PREVENTION 
 
4.8.1 Responses of those who have heard about IPT 
 
Table 4.41 Responses of those who have heard about IPT 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
YES 216 72.0 
NO 84 28.0 
TOTAL 300 100.0 
 
 
Figure 4.36 Responses of those who have heard about IPT 
 
Of the respondents, 216 (72.0%) said they had heard about IPT. This is lower than but 
comparable to the study conducted by Akaba et al (2012:203) where 84.4% were aware 
of IPT against malaria. In another study by Akinleye et al (2009:5) 52.2% had heard of 
IPT. 
 
  
72.0% 
28.0% 
YES
NO
  
89 
4.8.2 Where did you hear about IPT 
 
Table 4.42 Where did you hear about IPT 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
HOSPITAL POSTERS 79 26.3 
FRIENDS AND FAMILY 33 11.0 
RADIO/TELEVISION 5 1.7 
ANTENATAL CLINIC 183 61.0 
TOTAL 300 100.0 
 
 
Figure 4.37  Where did you hear about IPT 
 
Of the respondents, 183 (61.0%) heard about IPT at antenatal clinics, most of the 
respondents received the drugs at ANC as a result already know about IPT. 
 
This is a bit different from the results got from the study by Akinleye et al (2009:6) 
reported that 47.7% of their respondents heard about IPT from ANC clinic, 19.3% heard 
from radio/television, 9.2% heard from friends, 22.0% heard from clinic posters. 
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4.8.3 Since coming to this ANC Center have you received IPT drug? 
 
Table 4.43 Since coming to this ANC Center have you received IPT drug? 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
YES 254 84.7 
NO 36 12.0 
DON'T KNOW 10 3.3 
TOTAL 300 100.0 
 
 
Figure 4.38   Since coming to this ANC Center have you received IPT drug 
 
Of the respondents, 254 (84.7%) said they had received IPT drugs, 36 (12.0%) said 
they had not received IPT drugs while 10 (3.3%) did not know if they had received IPT 
drugs. 
 
Those who did not know if they had received the drugs might not have been told what 
the SP given to them were for and therefore might think it was part of their routine ANC 
drugs/multivitamins. Most of those who had not received the drugs are those still in their 
first trimester. 
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The percentage of women who received IPT in this study was similar to the study by 
Aduloju et al (2013:6) in Ado-ekiti Nigeria where 74.7% pregnant women received IPT 
drug while 25.3% did not. 
 
4.8.4 Number of tablets that was given 
 
Table 4.44 Number of tablets that was given 
 
NUMBER OF TABLET FREQUENCY PERCENT 
ONE 21 7.0 
TWO 4 1.3 
THREE 147 49.0 
FOUR 20 6.7 
FIVE 13 4.3 
SIX 41 13.7 
MISSING VALUE 54 18.0 
TOTAL 300 100.0 
 
Of the respondents, 21 (7.0%) said they were given one tablet, 4 (1.3%) said they were 
given two tablets, 147 (49.0%) said they were given three tablets, 20 (6.7%) said they 
were given four tablets, 13 (4.3%) said they were given five tablets, 41 (13.7%) said 
they were given six tablets while 54 (18.0%) did not answer this question.  
 
The finding here cannot be generalised because from some of their responses, they did 
not seem sure of their responses, also some people did not provide this answer as well. 
Akinleye et al (2009:8) reported that 7.0% of their respondents received less than three 
tablets of SP while 93.0% received three tablets, in their study, their respondents had a 
good knowledge of what drugs were given to them. 
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4.8.5 Where did you use it? 
 
Table 4.45 Where drugs were used 
 
NUMBER OF TABLET FREQUENCY PERCENT 
HOME 175 58.3 
IN THE CLINIC 32 10.7 
OUTSIDE THE CLINIC 10 3.3 
SOME IN THE CLINIC, SOME AT HOME 20 6.7 
NONE 17 5.7 
MISSING VALUE 46 15.3 
TOTAL 300 100.0 
 
 
 
Figure 4.39   Where drugs were used 
 
The place where the pregnant women use the drug ranges from home, in the clinic, 
outside the clinic, some in the clinic, some at home and none.  Of the respondents, 175 
(58.3%) which is the majority used the drug at home. It can be deduced from this 
finding that they were not being supervised while taking the drugs. 
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Table 4.46 When you used it, were you supervised? 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
NO 254 84.7 
YES 0 0 
MISSING VALUES 46 15.3 
TOTAL 300 100.0 
 
All the responses here are No, meaning that the nurses did not supervise any of the 
respondents. This is lower than the findings by Akinleye et al (2009:5) in southwest, 
Nigeria where only 14.3% said they were supervised. A study by Tobin-West and 
Asuquo (2013) showed that 16.4% took the drug at the health facility directly observed 
as against 71.4% who said they took theirs at home. 
 
Table 4.47 Was there a time you did not use the drug for fear of complication? 
 
TYPE OF RESPONSES FREQUENCY PERCENT 
YES 17 5.7 
NO 240 80.0 
MISSING VALUE 43 14.3 
TOTAL 300 100.0 
 
 
Figure 4.40   Possibility of not using the drugs for fear of complication 
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The responses were either yes or no. The majority of the respondents 240 (80.0%) 
answered no, 17 (5.7%) answered yes while 43 (14.3%) did not answer this question. 
This fear might be the reason why some of them did not take the drugs. 
 
This is similar to a study conducted in Rivers state Nigeria by Tobin-West and Asuquo 
(2013) where 62.8% of those who attended ANC took their drugs, while the rest (37.2%) 
said they did not. One of the reasons they gave for not taking their drugs was that they 
were afraid the drugs could cause loss of pregnancy. 
 
4.8.6 Was there any time you used IPT during pregnancy and still had malaria? 
 
Table 4.48 Was there any time you used IPT during pregnancy and still had 
malaria? 
NUMBER OF TABLET FREQUENCY PERCENT 
YES 32 10.7 
NO 178 59.3 
DON'T KNOW 44 14.7 
MISSING VALUE 46 15.3 
TOTAL 300 100.0 
  
 
Figure 4.41  Was there any time you used IPT during pregnancy and  
still had malaria? 
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The types of responses if there was any time you used IPT during pregnancy and still 
had malaria in pregnancy for pregnant woman ranges from don’t know response, yes 
response or no response with the majority being 178 (59.3%) who did not have malaria. 
The study results therefore concluded that out of the 300 responses we got from the 
pregnant women, most pregnant women did not have malaria after taking the drugs as 
reflected above. 
 
Although 32 (10.7%) of them still reported they had malaria after taking the drugs and 
44 (14.7%) said they did not know if they had malaria or not, this could be as a result of 
non-compliance. 
 
This is lower than a study conducted in Zambia by Mulamba and Mash (2010) where 
15.8% of their participants reported having suffered from malaria during their current 
pregnancy even after taking two doses of SP. IPTp with SP remains effective in 
preventing the adverse consequences of malaria on maternal and fetal outcomes (WHO 
2013:4). 
 
4.9 CONCLUSION  
 
This chapter discussed the data analysis and interpretation with reference to the 
literature review. The aim of this study was to assess the knowledge and use of IPT 
among pregnant women receiving ANC in health centers of the Federal Capital 
Territory. The main findings of the investigation were summarised in each section. 
Chapter 5 concludes the study, discusses its limitations and makes recommendations 
for practice and further research. 
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CHAPTER 5 
 
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
This chapter presents the summary, limitations and recommendations of the study. 
 
5.2 SUMMARY OF THE STUDY 
 
The purpose of this study was to investigate the knowledge and use of IPT among 
pregnant women receiving antenatal care in the primary health care centers of the 
Federal Capital Territory (Abuja), Nigeria. 
 
The objectives of this study were to 
 
• determine the level of knowledge and use of IPT among pregnant women 
attending ANC in health centers in Abuja, Nigeria 
• identify factors (socio-economic and cultural) that may influence IPT uptake 
among the pregnant women attending ANC in health centers, in Abuja Nigeria 
 
A quantitative, descriptive research approach was adopted. The target population was 
pregnant women who attended ANC in Abuja health centers between July and August 
2012. 
 
The researcher used probability (random) sampling. 300 pregnant women were the 
respondents. The data collection instrument was a structured questionnaire and data 
analysis was done using the SPSS version 22.0. 
 
5.3 FINDINGS ON THE PREGNANT WOMEN 
 
The first objective of the study which is to determine the level of knowledge and use of 
IPT among pregnant women attending ANC in health centers in Abuja, Nigeria. The 
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data revealed a good knowledge of malaria, its symptoms and control, but a poor 
knowledge of its effects on pregnancy, a certain level of non-compliance was also seen. 
 
5.3.1 Objective 1 
 
To determine the level of knowledge and use of IPT among pregnant women attending 
ANC in health centers in Abuja, Nigeria. 
 
• Malaria transmission and symptoms of malaria 
 
All of the respondents 300 (100%) agreed that mosquito is a vector that transmits 
malaria. The majority of the pregnant women had knowledge regarding the signs and 
symptoms of malaria; this was evidenced by their ability to agree with signs of malaria 
such as fever, headache, chills, sweating and vomiting. Only a less number did not 
know or were unsure of the signs and symptoms of malaria. Their knowledge on the 
transmission and symptoms of malaria was good. Center for Diseases Control (2015:1) 
also emphasised that malaria is only transmitted by the Anopheles mosquito which is in 
line with this study. 
 
• Malaria prevention and control 
 
The majority of the pregnant women had good knowledge regarding malaria prevention 
and control; this was shown by their ability to agree with the following: wearing long 
sleeve clothes, use of ITN, trimming of bushes around the house, use of insecticide 
spray, taking preventive drugs. Only a less number did not know the methods of 
prevention and control. 
 
• Effects of malaria in pregnancy 
 
The majority of the pregnant women had poor knowledge regarding the effect of malaria 
in pregnancy; this was revealed by their inability to agree with the following effects: still 
birth, low birth weight, maternal death and abortion.  
 
Their insufficient knowledge of the effects of malaria in pregnancy should be of great 
concern to the health workers and policy makers. 
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These findings on the effect of malaria in pregnancy does not agree with the study by 
Tobin-West and Asuquo (2013) that Most of the women in their study (71.4%) had 
knowledge that malaria could cause some harm during pregnancy to the mother or fetus 
such as abortion, still births, or low birth weight. 
 
On whether the nurses give health talks on malaria, 37(12.3%) said yes and 
263(87.7%) answered no. 
 
• Practice regarding malaria prevention 
 
The majority of the pregnant women had good knowledge about IPT, more than half of 
them had heard of IPT and more than half of them had received IPT drugs but some of 
them seem to be unsure of how many tablets were given to them. From their responses, 
there were not observed by the nurses while taking the drugs although more than half of 
them took their drugs. A few of them who did not take their drugs were afraid of possible 
complications.  
 
5.3.2 Objective 2 
 
To identify factors (socio-economic and cultural) that may influence IPT uptake among 
the pregnant women attending ANC in health centers, in Abuja Nigeria. 
 
Mothers within the age group of 26-30 years, from the Hausa ethnic group, with 
secondary education and were married had good IPT uptake. Also, housewives and low 
income earners had good IPT uptake as well, see Annexure 1. 
 
5.4 LIMITATIONS OF THE STUDY 
 
The study focused on health centers therefore the findings cannot be generalised. The 
centers where the study was conducted was in an urban setting with very few of the 
respondents from the peri-urban area. If a larger rural area were included, it could have 
led to different data and findings. 
 
It was observed also that some of the respondents did not provide answers to some 
questions in the questionnaire. 
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However, despite the limitation, the results have elicited important information that could 
serve as a basis to re-visit the way health talk on malaria and its effect on pregnancy is 
given at health centers. 
 
5.5 RECOMMENDATIONS 
 
Based on the findings of this study, the following issues should be considered for 
improving malaria prevention among pregnant women. 
 
5.5.1 Nursing practice 
 
Enhancement of pregnant women’s knowledge on malaria prevention by the nurses is 
still needed in these health centers, the need to emphasise especially on the effects of 
malaria in pregnancy, more information about the drug should be provided and 
explained in detail what could happen if the medication is not taken completely for 
example drug resistance.  
 
Intensifying education about IPT in communities will add to the knowledge of the 
pregnant women and thus encourage them to attend ANCs early enough to receive all 
the recommended doses of SP. 
 
The nurses should also insist that the pregnant women take their medications under 
supervision. 
 
5.5.2 Nursing education 
 
Should incase health workers are not adequately trained on the quality and content on 
health talks given at ANC, formal training and retraining of the health workers in these 
health centers has the potential to further improve the utilisation of IPT among the 
pregnant women.  
 
All health care providers should be trained on, and have access to, the updated WHO 
guidelines on IPTp administration. 
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5.5.3 Nursing administration 
 
Clean water and disposable cups should be made available in each health center. 
Monitoring and supervision of IPT programme should be stepped up because it would 
also contribute to high commitment of the health staff to the program. 
 
5.5.4 Research 
 
Operational research is needed to evaluate strategies, both existing and new, that are 
designed to increase antenatal care-seeking behaviour, especially early in pregnancy, 
and to improve healthcare provider attitudes exhibited towards pregnant women who 
present at ANC facilities. Further operational research is needed to evaluate community 
distribution of IPTp that seeks to increase IPTp uptake while not discouraging ANC 
attendance. Continued collaboration with WHO and Ministries of Health will be required 
to monitor IPTp effectiveness and to foster data-driven decision-making by programme 
managers to identify bottlenecks in IPTp provision and prioritise appropriate action. 
 
Further studies should attempt to determine the rates of malaria throughout pregnancy. 
More research needs to be conducted to evaluate the situation in rural areas and 
amongst those women who give birth at home with the help of traditional birth 
attendants. 
 
5.5 CONCLUSION 
 
This chapter concluded the study, described its limitations and made recommendations 
for improved practice. 
 
The data obtained revealed the knowledge, attitude and use of IPT among pregnant 
women. 
 
The pregnant women had a good understanding of malaria, its mode of transmission 
and its symptoms but their knowledge on the effects of malaria on pregnancy was 
limited. It was also discovered that some of the respondents did not really understand 
the importance of IPT, 17(5.7%) of those who were given SP did not take it at all. 
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Despite the shortcomings of this research, the results would serve as a knowledge base 
on which to build strategies for improving the knowledge of the effects of malaria in 
pregnancy and IPT. The results would be useful for policy makers, IPT programme 
planners and health workers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
102 
LIST OF REFERENCES 
 
Abasiattai, AM, Etukumana, EA & Umoiyoho, AJ. 2009. Awareness and practice of 
malaria prevention strategies among pregnant women in Uyo, South South Nigeria. 
International Journal of Gynecology and Obstetrics 1(11):1-6. 
 
Abdullahi, K, Abubakar, U, Adamu, T, Daneji, AI, Aliyu, RU, Jiya, N, Ibraheem, MTO & 
Nata’ala, SU. 2009. Malaria in Sokoto, North Western Nigeria. African Journal of 
Biotechnology 8(24):7101-7105. 
 
Adebusoye, PM. 2006. Hidden: A profile of married adolescents in Northern Nigeria. 
Available from <http://www.actionhealthinc.org/publications/docs/hidden.pdf>. 
(accessed 18 December 2015). 
 
Adefioye, OA, Adeyeba, OA, Hassan, WO & Oyeniran, OA. 2007. Prevalence of Malaria 
parasite infection among pregnant women in Osogbo, Southwest, Nigeria. American-
Eurasian Journal of Scientific Research 2(1):43-45. 
 
Aduloju, OP, Ade-Ojo, IP, Olaogun, OD, Olofinbiyi, BA & Akintayo, AA. 2013. Effect of 
intermittent preventive treatment of malaria on the outcome of pregnancy among 
women attending antenatal clinic of a Nigerian Teaching Hospital. Tropical Journal of  
Obstetric Gynaecology 30(1):7-15. 
 
Akaba, GO, Otubu, J, Agida, ET & Onafowokan, O. 2013. Knowledge and utilization of 
malaria preventive measures among pregnant women at a tertiary hospital in Nigeria's 
Federal Capital Territory. Nigeria Journal of Clinical Practice 16(2):201-206. 
 
Akinleye, SO, Falade, CO & Ajayi, IO. 2009. Knowledge and utilization of intermittent 
preventive treatment for malaria among pregnant women attending antenatal clinics in 
primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC 
Pregnancy and Childbirth 9(28):1-8. 
 
Alemu, A, Abebe, G, Tsegaye, W & Golassa, L. 2011. Climatic variables and malaria 
transmission dynamics in Jimma town, South West Ethiopia, Parasites and Vectors 
4(30):1-11. 
  
103 
 
Alumran, A, Hou, X, Sun, J, Yousef, AA & Hurst, C. 2014. Assessing the construct 
validity and reliability of the parental perception on antibiotics (PAPA) scales. BMC 
Public Health 14(3)2-3. Available at: http://www.biomedcentral.com/1471-2458/14/73 
(accessed 12 December 2015). 
 
Arulogun, S & Okereke, C. 2012. Knowledge and practices of intermittent 
preventivetreatment of malaria in pregnancy among health workers in a southwest local 
government area of Nigeria. Journal of Medicine and Medical Sciences 3(6):415-422. 
 
Astatkie, A. 2010. Knowledge and practice of malaria prevention methods among 
residents of Abba Minch town and Abba Minch Zuria district, southern Ethiopia. 
Ethiopian Journal of Health Sciences 20(3):185-193. 
 
Bassey, BE, Asor, JE & Useh, MF. 2007. Profile of malaria in pregnant women 
attending antenatal clinics in rural community in Nigeria. The Open Parasitology Journal 
1:1-6. 
 
Bhattacherjee, A. 2012. Social science research: principles, methods, and practices. 2nd 
edition. Textbooks Collection. Book 3.   
Available at: http://scholarcommons.usf.edu/oa_textbooks/3 (accessed 30 January 
2016). 
 
Bialocerkowski, AE & Bragge, P. 2008. Measurement error and reliability testing: 
Application to rehabilitation. International Journal of Therapy and Rehabilitation 
15(10):422-427. 
 
Bouyou-Akotet, MK, Ionete-Collard, DE, Mabika-Manfoumbi, M, Kendjo, E, Matsiegui, 
P, Mavoungou E & Kombila, M. 2013. Antenatal care visit attendance, intermittent 
preventive treatment and bed net use during pregnancy in Gabon. Malaria Journal 
13(52):1-6. 
 
Brabin, BJ, Wasame, M, Ussenfeldt-Wort, U, Dellicour, S, Hill, J & Gies, S. 2008. 
Monitoring and evaluation of malaria in pregnancy – developing a rational basis for 
control. Malaria Journal 7(Suppl 1):S6. 
  
104 
 
Briand, V, Cottrel, G, Massougbodji, A & Cot, M. 2007. Intermittent preventive treatment 
for the prevention of malaria during pregnancy in high transmission areas. Malaria 
Journal 6(160): 1-7. 
 
Burns, N & Grove, SK 2005. The practice of nursing research; conduct, critique and 
utilization, 5th edition, Elsevier Saunders, St. Louis Missouri. 
 
Castillo, JJ. 2009. Simple random sampling. Available from: http://www.experiment-
resources.com/simple-random-sampling.html (accessed 27 December 2013). 
 
CDC see Centers for Disease Control. 
 
Centers for Disease Control and Prevention. 2015a. Anopheles mosquitoes.  Available 
from: http://www.cdc.gov/malaria/about/biology/mosquitoes/ (accessed 29 January 
2015).  
 
Centers for Disease Control and Prevention. 2015b. Impact of malaria. Available at: 
http://www.cdc.gov/malaria/malaria_worldwide/impact.html (accessed 27 October 
2015).  
 
Chikwasha, V, Phiri, I, Chimberengwa P, Bangure, D & Rusakaniko, S. 2014. Predictors 
of IPTp Uptake among Pregnant Women in the 2010-2011 Zimbabwe Demographic and 
Health Survey, DHS Working Papers No. 112 (Zimbabwe Working Papers No. 13). 
Rockville, Maryland, USA: ICF International. 
 
Chukwuocha, UM, Dozie, IN & Chukwuocha, AN. 2012. Malaria and its burden among 
pregnant women in parts of the Niger Delta area of Nigeria. Asian Pacific Journal of 
Reproduction 1(2):147-151. 
 
Creswell, JW, Knight, V, Connely, S & Scott, MP (eds). 2009. Research design, 
qualitative, quantitative and mixed methods approaches. 3rd edition. Los Angeles: Sage. 
 
  
105 
Deloron, P, Bertin, G, Briand, V, Massougbodji, A & Cot, M. 2010. 
Sulfadoxine/Pyrimethamine Intermittent preventive treatment for malaria during 
pregnancy. Emerging Infectious Diseases 16(11):1666-1670. 
 
Denoeud, L, Fievet, N, Aubouy, A, Ayemonna, P, Kinnifo, R, Massougbodji, A & Cot, M. 
2007. Is chloroquine chemoprophylaxis still effective to prevent low birth weight? 
Results of a study in Benin.  Malaria Journal 6(27):1-8. 
 
Ejik, A, Hill, J, Alegana, V, Kirui, V, Gething, P, Kuile, F & Snow, R. 2011. Coverage of 
malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis 
of national survey data' Lancet Infectious Diseases 11:190-207.  
Available at: http://doi.org/10.1016/S1473-3099(10)70295-4. (accessed 4 April 2014). 
 
Enato, EF, Okhamofe, AO & Okpere, EE. 2007. A survey of Knowledge, attitude and 
practice of malaria management among pregnant women from two health care facilities 
in Nigeria. Acta Obsetetrica et Gynecologica Scandinavica 86:33-35.  
 
FCT MDG Baseline. 2009. Federal Capital Territory Millennium Development Goals. 
Available from: http://www.mdgfctabuja.net/Baseline10/baseline10.aspx (accessed 5 
February 2016).  
 
Federal Capital Territory Administration. 2015. Available from: http://www.abuja-
ng.com/federal-capital-territory.html (accessed 5 February 2016). 
 
Federal Ministry of Health. 2008. National malaria control programme, Abuja, Nigeria. 
Strategic Plan 2009-2013. A Road Map for Malaria Control in Nigeria 2008.  
 
Federal Ministry of Health. 2010. National malaria control programme. Advocacy, 
communication and social mobilization strategic framework and implementation plan.  
 
Federal Ministry of Health. 2011. National policy on malaria diagnosis and treatment. 
Federal Ministry of Health National Malaria and Vector Control Division Abuja-Nigeria. 
 
FMOH see Federal Ministry of Health. 
  
106 
Fouka, G & Mantzorou, M. 2011. What are the major ethical issues in conducting 
research? Is there a conflict between the research ethics and the nature of nursing? 
Health Science Journal 5(1):3-14. 
 
Global Health Policy. 2015. The US government and global malaria. Available at: 
http://kff.org/global-health-policy/fact-sheet/the-u-s-government-and-global-malaria/ 
(accessed 10 August 2015). 
 
Greenwood, BM, Fidock, DA, Kyle, DE, Kappe, SHI, Alonso, PL, Collins, FH & Duffy, 
PE. 2008, Malaria: progress, perils and prospects for eradication. The Journal of Clinical 
Investigation 118(4):1266-1276. 
 
Gross, K, Alba, S, Schellenberg, J, Kessy, F, Mayumana, I & Obrist, B. 2011. The 
combined effect of determinants on coverage of intermittent preventive treatment of 
Malaria during pregnancy in the Kilombero valley, Tanzania, Malaria Journal 10(140):1-
12. 
 
Grove, SK, Burns, N & Gray, R.  2012. The practice of nursing research; conduct, 
critique and utilization. 7th edition. St Louis, Missouri: Elsevier Saunders.  
 
Hill, JA. 2014. Systematic assessment of factors affecting the delivery, access and use 
of interventions to control malaria in pregnancy in sub-Saharan Africa. A dissertation 
submitted to the institutional repository of the University of Amsterdam (UvA). 
 
Ifenne, DI & Utoo, BT. 2012. Gestational age at booking for antenatal care in a tertiary 
health facility in north-central, Nigeria. Nigerian Medical Journal 53(4):236-239.  
Available from: http://www.nigeriamedj.com/article.asp?issn=0300-
1652;year=2012;volume=53;issue=4;spage=236;epage=239;aulast=Ifenne (accessed 6 
March 2015). 
 
Igbodekwe, FC, Oladimeji, O, Oladimeji, KE, Adeoye, IA, Akpa, OM & Lawson, L. 2014. 
Utilisation of modern contraceptive among women of childbearing age in resource 
constraint setting: Evidence from 2008 National Demographic and Health Survey in 
Nigeria. Journal of Health Science 4(3):72-78. 
 
  
107 
Igboeli, UN, Adibe, OM & Aguwa, N. 2014. Knowledge and practice pattern of malaria 
prevention and control in pregnancy by healthcare providers within the context of 
focused antenatal care in Enugu State, Nigeria. International Journal of Tropical 
Disease and Health 4(8):905-916. 
 
Igunma, Y, Ande, A, Ezeanochie, M & Hayes, K. 2010. Malaria in pregnancy: 
experience with intermittent preventive treatment in a university teaching hospital in 
southern Nigeria. Benin Journal of postgraduate medicine 12(1):14-19. 
 
Japhet, YA. 2014, Comprehensive guide to research methodology. 21 December 2014. 
Yaya A Japhet: Blog. Available from: http://nairaproject.com/m/blog/006.html (accessed 
05 February 2016). 
 
Kimberly, CL & Winterstein, AG. 2008. Validity and reliability of measurement 
instruments used in research. American Journal of Health-System Pharmacists 
65(84):2276-2284. 
 
Kiwuwa, MS & Mufubenga, P. 2008. Use of antenatal care, maternity services, 
intermittent presumptive treatment and insecticide treated bed nets by pregnant women 
in Luwero district, Uganda. Malaria Journal 7(44):1475-2875. 
 
Leon, AC, Davis, LL & Kraemer, HC. 2011. The role and interpretation of pilot studies in 
clinical research. Journal of Psychiatric Research 45(5):626-629.  
 
Manyando, C, Kayentao, K, D'Alessandro, U, Okafor, HU, Juma, E & Hamed, K. 2012. 
A systematic review of the safety and efficacy of artemether-lumefantrine against 
uncomplicated Plasmodium falciparum malaria during pregnancy. Malaria Journal, 11, 
(141):1-13. 
 
Mbonye, AK, Neema, S & Magnussen, P. 2005. Preventing malaria in pregnancy: A 
study of perceptions and policy implications in Mukono district, Uganda. Available at: 
http://heapol.oxfordjournals.org/ (accessed 01 October 2012). 
 
McLeod, SA. 2014. Sampling methods.  
Available from: www.simplypsychology.org/sampling.html (accessed 05 February 2016). 
  
108 
 
Medugu, NI. 2009. Overview of FCT, Abuja and its planning concept. 9 August 2009. 
Nasiru Idris Medugu: Blog.  
Available from: https://environmentalsynergy.wordpress.com/2009/08/14/overview-of-
fct-abuja-and-its-planning-concept/ (accessed 05 October 2014). 
 
Mens, PF, Scheelbeek, FP, Atabbi, AI & Enato, FO. 2011. Peer education: The effects 
on knowledge of pregnancy related malaria and preventive practices in women of 
reproductive age in Edo State, Nigeria’. BMC Public Health 11(610):1-9. 
 
Merriam-Webster English Dictionary. 2011. Available at: http://www.merriam-
webster.com/dictonary/knowledge (accessed 08 December 2012). 
 
Mouton, J. 2001. How to succeed in your master’s and doctoral studies: a South African 
guide and resource book. Pretoria: Van Schaik. 
 
Mubyazi, A, Bloch, P, Kamugisha, M, Kituua, A & Ijimba, J. 2005. Intermittent preventive 
treatment of malaria during pregnancy: A qualitative study of knowledge, attitudes and 
practices of district health managers, antenatal care staff and pregnant women in 
Korogwe district, Northern eastern Tanzania. Malaria Journal 4(31):1-10. 
 
Mulamba, M & Mash, B. 2010. Evaluation of malaria prevention strategies during 
pregnancy in Ndola, Zambia. African Journal of  Primary Health Care&  Family Medicine 
2(1) Available from: <http://www.phcfm.org/index.php/phcfm/article/view/159/141> 
(accessed: 03 February 2016). 
 
National Bureau of Statistics. 2012. Social statistics in Nigeria. Part III: health, 
employment, public safety, population and vital registration. Available at: 
www.nigerianstat.gov.ng/pages/download/170 (accessed 03 March 2014). 
 
National Malaria Control Programme (NMCP). 2010. Malaria household survey in nine 
states of Nigeria: Malaria Control Booster Project. Federal Ministry of Health. 
 
NETMARK. 2000. Isecticide treated nets in Nigeria. NETMARK Regional Africa 
programme briefing book, September 2000. 
  
109 
 
Nwali, MI, Ejikeme, BN, Agboeze JJ, Onyebuchi, AK & Anozie, BO. 2015. Plasmodium 
falciparum parasitaemia among booked parturients who received two doses of 
sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy 
(IPTp) in a tertiary health facility Southeast Nigeria. Nigerian Medical Journal 56(218):2. 
Available from: http://www.nigeriamedj.com/text.asp?2015/56/3/218/160406 (accessed 
03 January 2016). 
 
Nwonwu, EU, Ibekwe, PC, Obarezi, HC & Nwagbara, OC. 2009. Prevalence of malaria 
parasitaemia and malaria related anaemia among pregnant women in Abakaliki, South 
east Nigeria. Nigerian Journal of Clinical Practice 12(2):182-186. 
 
Nwosu, J, Odubanjo, MO & Osinusi, BO (eds). 2009. The Nigerian Academy of 
Science, reducing maternal and infant mortality in Nigeria (Workshop Summary). Lagos, 
Nigeria: West Africa. 
 
Obol, J, Lagoro, KD & Garimoi, OC. 2011. Knowledge and misconceptions about 
malaria among pregnant women in a post-conflict internally displaced persons' camps in 
Gulu District, Northern Uganda. Malaria Research and Treatment. Available from: 
http://www.hindawi.com/journals/mrt/2011/107987 (accessed 09 October 2015). 
 
Okpere, EE, Enabudoso, EJ & Osemwenkha, AP. 2010. Malaria in pregnancy. Nigeria 
Medical Journal.   
Available from: http://www.nigeriamedj.com/text.asp?2010/51/3/109/71013 (accessed 
05 July 2015). 
 
Okwa, OO, Akinmolayan, FI, Carter, V & Hurd, H. 2009. Transmission dynamics of 
malaria in four selected ecological zones of Nigeria in the rainy season. Annals of 
African Medicine 8(1):1-9. 
 
Okwa, OO & Ibidapo, AC. 2010. The malaria situation, perception of cause and 
treatment in a Nigerian University. Journal of Medicine and Medical Sciences 1(6):213-
222. 
 
  
110 
Olayemi, IK, Ande, AT, Ayanwale, AV, Mohammed, AZ, Bello, IM, Idris, B, Isah, B, 
Chuwuemeka, V & Ukubuiwe, AC. 2011. Seasonal trends in epidemiological profiles of 
malaria transmission in North Central Nigeria. Pakistan Journal of Biological Sciences 
14(4):293-299. 
 
Omair, A. 2014. Sample size estimation and sampling techniques for selecting a 
representative sample. Journal of Health Specialties 2(4):142-147. 
 
Omaka-Omari, LN & Nwimo, IO. 2015. Pregnant women's malaria knowledge in Ebonyi 
State, South-East Nigeria. Research on Humanities and Social Sciences 5(10):165-173. 
 
Onoka, CA, Hanson, K & Onwujekwe, OE. 2012. Low coverage of intermittent 
preventive treatment for malaria in pregnancy in Nigeria: demand-side influences. 
Malaria Journal 11(82):1-8. 
 
Onwuegbuzie, AJ & Collins, KMT. 2007. A typology of mixed methods sampling designs 
in social science research. The Qualitative Report 12(2):281-316. 
 
Onwumele, A. 2014. An assessment of the spatial pattern of malaria infection in Nigeria. 
International Journal of Medicine and Medical Sciences 6(2):80-86. 
 
Peter, AO. 2013. Effect of intermittent preventive treatment of malaria on the outcome of 
pregnancy among women attending antenatal clinic of a new Nigerian teaching hospital, 
Ado-Ekiti. Nigerian Medical Journal : Journal of the Nigeria Medical Association 
54(3):170-175. Available at: http://doi.org/10.4103/0300-1652.114582 (accessed 03 
February 2016). 
 
Polit, DF & Beck, CT. 2008. Nursing research: principles and methods. 8th edition. 
Philadelphia: Wolters Kluwer/Lippincott, Williams and Wilkins. 
 
Polit, DF & Beck, CT. 2012. Nursing research: principles and methods, 7th edition. 
Lippincott, Williams and Wilkins, Philadelphia: Wolters Kluwer.  
 
President’s Malaria Initiative. 2010. FY 2011 malaria operational plan. Nigeria. October 
2010. 
  
111 
 
Purohit, B & Mahaptra, A. 2009. A review on high burden of malaria in pregnancy: Need 
of social science intervention. Ethno-Medicine 3(1):33-38. 
 
Rajasekar, S, Philominathan, P & Chinnathambi, V. 2013. Research methodology. 
Available from: http://www.arxiv.org/pdf/physics/0601009 [physics.ed-ph]14 Oct 2013 
(accessed 06 June 2015). 
 
Responsible Conduct in Data Management. 2009.  
Available from: 
https://ori.hhs.gov/education/products/n_illinois_u/datamanagement/datopic.html 
(accessed [12 December 2015). 
 
Ricci, F. 2012. Social implications of malaria and their relationships with poverty. 
Mediterranean Journal of Hematology And Infectious Diseases 4(1) Available from: 
<http://www.mjhid.org/index.php/mjhid/article/view/344/472>. (accessed 14 July 2015). 
 
Roach, KE. 2006. Measurement of Health Outcomes: Reliability, Validity and 
Responsiveness. Journal of Prosthetics and Orthotics 18(1s). 
Available from: http://www.oandp.org/jpo/library/2006_01S_008.asp (accessed 28 
January 2016).  
 
Sabin, LL, Rizal, A, Brooks, MI, Singh, MP, Tuchman, J, Wlie, BJ, Joyce, KM, Yeboa-
Antwi, K, Singh, N & Hamer, DH. 2010. Attitudes, knowledge and practices regarding 
malaria prevention and treatment among pregnant women in Eastern India. The 
American Society of Tropical Medicine and Hygiene 82(6):1010-1016. 
 
Salihu, OM & Sanni, NA. 2013. Malaria burden and the effectiveness of malaria control 
measures in Nigeria: A case study of Asa Local Government Area of Kwara State. 
Journal of Economics and Sustainable Development 4(3):295-308. 
 
  
  
112 
Samak, AC. 2004. Malaria in pregnancy: An overview. McGill Journal of Medicine 
8(1):66-71. 
 
Schantz-Dunn, J & Nour, NM. 2009. Malaria and pregnancy: A global health 
perspective. Reviews in Obstetrics and Gynecology 2(3):186-192. 
 
SERAC. 2006. Pushing out the poor: Forced evictions under the Abuja master plan. 
Social and Economic Rights Action Center (SERAC).  
 
Sedgwik, P. 2014. Cross sectional studies: advantages and disadvantages. British 
Medical Journal 348:g2276. (Published 26 March 2014). Available from: 
<http://www.bmj.com/content/348/bmj.g2276> (accessed 03 February 2016) 
 
Shretta, R & Kwiecien, A. 2010. Intermittent preventive treatment with Sulfadoxine 
Pyrimethamine in Burundi; Submitted to the U.S. Agency for International Development 
by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington, VA: 
Management Sciences for Health. 
 
Stommel, M & Wills, C. 2004. Clinical research: Concepts and principles for advanced 
practice nurses. Philadelphia: Lippincott Williams & Wilkins. 
 
Thanabouasy, C. 2008. Assesment of knowledge, attitiude and practice regarding 
malaria prevention towards population in Paksong District, Champasack Province, LAO 
PDR. A thesis submitted to the College of Public Health Sciences, Chulalongkorn 
University. 
 
Thiam, S, Kimotho, V & Gatonga, P. 2013. Why are IPTp coverage targets so elusive in 
sub-Saharan Africa? A systematic review of health system barriers. Malaria Journal 
12(353):1-3. 
 
Tobin-West, CI & Asuquo, E.O. 2013. Utilization of intermittent preventive treatment of 
malaria by pregnant women in Rivers State, Nigeria. International Journal of Preventive 
Medicine 4(1):63-71. Available from:  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570914/ (accessed 21 December 2015) 
 
  
113 
Tonga, C, Kimbi, HK, Anchang-Kimbi, JK, Nyabeyeu, HN, Bissemou, ZB & Lehman, 
LG. 2013. Malaria risk factors in women on intermittent preventive treatment at delivery 
and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. PLoS ONE 
8(6):1. Available from: http://doi.org/10.1371/journal.pone.0065876 (accessed 06 June 
2014). 
 
Udo-Akang, D. 2013. Ethical orientation for new and prospective researchers. American 
International Journal of Social Science 2(1):54-64. 
 
Ujoh, F, Kwabe, ID & Ifatimehin, OO. 2010. Understanding urban sprawl in the Federal 
Capital City, Abuja: Towards sustainable urbanization in Nigeria. Journal of Geography 
and Regional Planning 3(5):106-113. 
 
Uneke, C. J. 2008. Impact of Placental Plasmodium falciparum Malaria on Pregnancy 
and Perinatal Outcome in Sub-Saharan Africa: Part III: Placental Malaria, Maternal 
Health, and Public Health. The Yale Journal of Biology and Medicine, 81(1): 1–7. 
 
UNFPA. 2010. Healthcare services in UNFPA assisted states of Nigeria, Nigeria 
Country Office 2010. FCT Abuja report. 
 
United States Embassy in Nigeria. 2011. Nigeria malaria fact sheet. Available from: 
http://photos.state.gov/libraries/nigeria/231771/Public/DecemberMalariaFactSheet2.pdf 
(accessed 06 April 2013). 
 
Uzochukwu, BSC, Ezeoke, OP, Emma-Ukaegbu, U, Onwujekwe, OE & Sibeudu, FT. 
2010. Malaria treatment services in Nigeria: A review. Nigerian Medical Journal 
51(3):114-119. 
 
Vallely, A, Vallely, L, Changalucha, J, Greenwood, B & Chandramohan, D. 2007. 
Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's 
needed? Malaria Journal 6(16):1-13. 
 
  
  
114 
WHO see World Health Organization. 
 
World Health Organization. 2013. WHO policy brief for the implementation of 
intermittent preventive treatment of malaria in pregnancy using sulfadoxine-
pyrimethamine (IPTp-SP).  
Available from: http://www.who.int/malaria/publications/atoz/iptp-sp-updated-policy-
brief-24jan2014.pdf (accessed 04 January 2014). 
 
World Health Organization. 2015. Malaria.  
Available from: <http://www.who.int/mediacentre/factsheets/fs094/en/> [29 January 
2015]. 
 
  
115 
ANNEXURE 1: Factors (socio-economic and cultural) that may 
influence IPT uptake among the pregnant women attending ANC in 
health centers, in Abuja Nigeria 
Association between socio-demographic characteristics and IPT use 
Table 5.1 Age group 
Age group 
(years) 
Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
15-20 18 7.1 9 3.5 
21-25 29 11.4 2 0.8 
26-30 80 31.5 1 0.4 
31-35 49 19.3 1 0.4 
36-40 55 21.7 1 0.4 
41-45 6 2.4 2 0.8 
46-49 0 0 1 0.4 
Total 237 93.4 17 6.7 
 
Table 5.2 Ethnic group 
Ethnic group Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
Yoruba 21 8.3 2 0.8 
Igbo 23 9.1 4 1.6 
Hausa 137 53.9 3 1.2 
Others 56 20.9 8 3.2 
Total 237 92.2 17 6.8 
 
Table 5.3 Educational level 
Educational 
level 
Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
Quranic School 2 0.8 9 3.5 
Primary School 10 3.9 4 1.6 
Secondary 100 39.7 2 0.8 
University 84 33.1 1 0.4 
Others 41 16.1 1 0.4 
Total 237 93.6 17 6.7 
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Table 5.4 Marital status 
Marital status Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
Single 82 32.3 9 3.5 
Married 122 48.0 4 1.6 
Widowed 13 5.1 2 0.8 
Divorced 10 3.9 1 0.4 
Separated 10 3.9 1 0.4 
Total 237 93.2 17 6.7 
 
Table 5.5 Occupation 
Occupation Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
Teacher 10 3.9 3 1.2 
Business 48 18.9 4 1.6 
Housewife 52 20.1 0 0 
Farmer 1 0.4 2 0.8 
Student 34 13.4 3 1.2 
Unemployed 42 16.5 5 2.0 
Health 
personnel 
8 3.1 0 0 
Others 42 16.5 0 0 
Total 237 92.8 17 6.8 
 
Table 5.6 Average family income per month 
Average family 
income per 
month 
Type of responses (Yes for those who received & took IPT, No for 
those who received & did not take IPT) 
Yes Percentage No Percentage 
0-17,999 36 14.2 8 3.1 
18,000-29,999 96 37.8 3 1.2 
30,000-39,999 42 16.5 4 1.6 
40,000-99,999 55 21.7 1 0.4 
100,000-above 8 3.1 1 0.4 
Total 237 93.3 17 6.7 
 
  
117 
ANNEXURE 2: APPROVAL FROM UNISA 
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ANNEXURE 3: LETTER OF PERMISSION TO FCDA, ABUJA 
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ANNEXURE 4: APPROVAL FROM FEDERAL CAPITAL DEVELOPMENT 
AUTHORITY (FCDA) 
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ANNEXURE 5: LETTER FROM EDITOR 
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ANNEXURE 6: CONSENT FORM 
 
Please read this form carefully and ask any question you may have before 
agreeing to take part in the study. 
 
Research title 
 
Knowledge and use of Intermittent prevention for Malaria among pregnant women 
attending Antenatal clinic in Health Centers in the Federal Capital erritory,Nigeria. 
 
What the study is about 
 
The purpose of the study is to assess the level of knowledge and use of intermittent 
preventive treatment (IPT) among women attending antenatal clinics in the health 
centers in Abuja. 
 
What you will be asked to do 
 
If you agree to be in this study, a questionnaire will be given to you. The questionnaire 
will take about 40 minutes to complete. You are requested to respond to each question 
to the best of your knowledge. 
 
Risks and benefits of the study 
 
Risks: The researcher does not anticipate any risks to you participating in this study 
other than those encountered in day-to-day life. This may just be mere inconvenience. 
 
Benefits: The study outcome will help improve the knowledge of malaria and IPT use 
among pregnant women so that maternal mortality and risks of malaria in pregnancy 
can be reduced. It will also help antenatal care staff and the government to identify 
areas to concentrate their efforts. 
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Your answers will be confidential 
 
The records of this study will be kept private. In any sort of report made public, 
information that will make it possible to identify you will not be included. The research 
records will be kept in a locked file, only the researchers will have access to the records. 
 
Taking part is voluntary 
 
Taking part in this study is completely voluntary. You may also skip any questions that 
you do not want to answer and you are free to withdraw from the study at any time, 
without giving any reason. 
 
If you have questions 
 
The researcher conducting this study is Dr. Obiageli Emenike. You are free to ask any 
questions now. If you have questions later, you may contact: 
 
Dr. Obiageli Emenike 
Tel:  08028430721  
E-mail: orbyemenike@gmail.com 
 
Statement of consent 
 
I have read the above information, and have received answers to any question I asked. 
I consent to take part in the study. 
Your signature……………………………………………...Date……………………… 
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ANNEXURE 7: QUESTIONNAIRE 
Instruction: Tick the boxes and/or fill in the gaps attached to the questions. 
(1) SECTION A: RELEVANT SOCIO DEMOGRAPHIC INFORMATION 
 
1. How old are you?..................... years 
 
2. What is your ethnic group? 
 1. Yoruba      2. Igbo   
 3. Hausa      4. Other (please specify)…………….. 
 
3. Are you currently? 
 1. Single    2. Married   3. Divorced 
 4. Widowed   3. Separated 
 
4. What is your education (the highest level of school you attended)? 
 1. Quranic school     2. Primary school 
 3. Secondary school     4. University   
 5. Other (please specify) …………………… 
 
5. What is your occupation i.e what kind of work do you mainly do? 
      1. Self-employed/Own small business   2. House wife 
      3. Farmer       4. Tailor 
      5. Teacher       6.  Student 
      7.  Unemployed      8.  Health Personnel  
      8.  Other (please specify)……………………. 
 
      6. What is your average family income? 
     About  ………………………… per month. 
 
6. For how long have you been Abuja? 
 1. One – two years 
 2.  Three – five years 
 3. More than five years 
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2) SECTION B: OBSTETRIC HISTORY 
1. How far in months are you pregnant today?  ……………………….. 
2. How many child births have you ever had?  ………………………… 
3. How many pregnancies have you ever had  ………………………… 
4. How long ago did you give birth to your last child before your current pregnancy? 
(if you haven’t had any child before, proceed to the next section). 
     1. Month   2. Year    0. Don’t know  
 
3) SECTION C: BASIC KNOWLEDGE ABOUT MALARIA 
No. Questions    Yes  No  Don’t Know 
 
1. Have you ever heard of malaria?             1   2   0 
2. Which vector can transmit malaria to 
human beings? 
2.1 Rats      1   2   0 
2.2 Dogs      1   2   0 
2.3 Mosquitoes     1   2   0 
2.4 House fly      1   2   0 
2.5 Cockroach     1   2   0 
3. What are the symptoms of malaria? 
3.1 Fever      1   2   0 
3.2 Headache     1   2   0 
3.3 Chill/Cold     1   2   0 
3.4 Itching      1   2   0 
3.5 Sweating      1   2   0 
3.6 Stomach pain     1   2   0 
3.7 Vomiting      1   2   0 
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4. Ways to prevent and control malaria    
4.1 Wearing long sleeve clothes   1   2   0 
4.2 Using insecticide treated nets (ITN)  1   2   0 
4.3 Trimming bushes around the house  1   2   0 
4.4 Taking malaria drugs before going   1   2   0 
  
  the forest. 
4.5 Insecticide spray    1   2   0 
4.6 Taking preventive drugs   1   2   0 
5. Effects of malaria in pregnancy are 
5.1 Still birth      1   2   0 
5.2 Low birth weight     1   2   0 
5.3 Maternal death     1   2   0 
5.4 Abortion      1   2   0 
5.5 Tuberculosis     1   2   0 
6. Breeding site of a mosquito 
6.1 Pond or lake     1   2   0 
6.2 Stagnant water     1   2   0 
6.3 Canal      1   2   0 
6.4 Dry and clean places    1   2   0 
 
4) SECTION D: SOURCE OF INFORMATION ABOUT MALARIA 
1. Have heard any information about malaria 
     1.  Yes      2. No   (if no please skip to section D) 
2. Which of the following source have you ever received the information about malaria?        
(more than one option can be ticked). 
 1. Hospital   2. Health center   3. Home (family member) 
 2. Community health leader  3. Neighbour  4. Drug hawker 
 3. Radio or Television  3. Other (please specify)……………………………… 
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3. Do health Nurses give talks on malaria?   
 1.  Yes      2. No    
 
5) SECTION E: PRACTICE REGARDING MALARIA PRVENTION 
1. Have you heard about Intermittent Preventive therapy (IPT)? 
     1. Yes    2. No 
2. From where did you hear about IPT? 
     2. Hospital posters  2. Friends  & family  3. Radio/television 
     4. Antenatal clinic  5. Other (please specify)……………………….. 
3. IPT can be given to? 
    3.1 Men    1. Yes  2. No  0. Don’t know 
    3.2 Women   1. Yes  2. No  0. Don’t know 
    3.3 Pregnant women  1. Yes  2. No  0. Don’t know 
    3.4 Infants    1. Yes  2. No  0. Don’t know 
4. When is IPT Doses recommended to be used during pregnancy?  
    4.1 1-3 Months   1. Yes  2. No  0. Don’t know 
    4.2 4-6 Months   1. Yes  2. No  0. Don’t know 
    4.3 7-9 Months   1. Yes  2. No  0. Don’t know 
5. Since your coming to this ANC center have you received IPT drug? 
     1. Yes  2. No  0. Don’t know 
6. How many tablets were you given? 
    6.1 One 
    6.2 Two 
    6.3 Three 
    6.4 Four 
    6.5 Other (please specify). 
7. How many did you use?........................... 
8. Where did you use it?   
     1. Home    2. In the Clinic      3. Outside the clinic 
     4. Some in the clinic, some at home    5. None 
9. When you used it, were you being supervised? 
     1. Yes    2. No   3. If yes, who supervised you? 
10. Is there any time you were afraid of any complication during pregnancy and   so    
didn’t use the drug? 
     1. Yes    2. No 
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11. Was there any time you used IPT during pregnancy and still had malaria? 
     1. Yes   2. No   0. Don’t know 
12. Do you and your family sleep in insecticide treated nets? 
     1. Yes    2. No 
13. Do you clear stagnant water around your house? 
     1. Yes    2. No   3. Occasionally 
14. Do you clear bushes around your house?  
     1. Yes    2. No   3. Occasionally 
15. Do you go to the hospital when you get sick? 
     1. Yes    2. No   3. Occasionally 
 
 
